iCoreConnect 10-K 24 Feb 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Jun. 30, 2013	Feb. 18, 2014	Dec. 31, 2012
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'iMedicor	'	'
Document Type	'10-K	'	'
Current Fiscal Year End Date	'--06-30	'	'
Entity Common Stock, Shares Outstanding	'	1,058,412,086	'
Entity Public Float	'	'	$31,331,794
Amendment Flag	'false	'	'
Entity Central Index Key	'0001408057	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Period End Date	30-Jun-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2013	Jun. 30, 2012
Current assets:	'	'
Cash	$513,272	$67
Accounts receivable, net of allowance for doubtful accounts of $-0- and $47,000 at June 30, 2013 and June 30, 2012, respectively	8,186	33,980
Total Current Assets	521,458	34,047
Intangible assets, net of accumulated amortization:	'	'
Technology and medical software, net	0	117,645
	0	117,645
Accounts Receivables in Litigation, net of allowance of $558,000 at June 30, 2012	0	62,000
	0	62,000
Total Assets	521,458	213,692
Liabilities:	'	'
Notes payable and accrued interest in default	4,820,361	4,389,636
Schneller payable	638,785	'
Employee/contractor payables	703,531	934,277
Accounts payable - trade	1,149,320	1,361,229
Other accrued expenses	0	520,549
Warrants - derivative liability	5,999,435	7,947
Conversion feature - derivative liability	0	920,427
Total Liabilities	13,311,432	8,134,065
Stockholders' Deficit	'	'
Common stock, par value $.001 per share, authorized 2,000,000,000 and 600,000,000 Issued and outstanding: 997,299,586 and 415,462,433 shares as of June 30, 2013 and June 30, 2012, respectively	997,299	415,462
Additional Paid in Capital	41,445,027	39,651,044
Accumulated deficit	-55,232,300	-47,986,879
Total Stockholders' Deficit	-12,789,974	-7,920,373
Total Liabilities and Stockholders' deficit	521,458	213,692
Series A Preferred Stock [Member]	'	'
Stockholders' Deficit	'	'
Preferred stock, value, issued	0	0
Series B Preferred Stock [Member]	'	'
Stockholders' Deficit	'	'
Preferred stock, value, issued	$0	$0

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Jun. 30, 2013	Jun. 30, 2012
Accounts Receivable, allowance for doubtful accounts (in Dollars)	$0	$47,000
Accounts Receivables in Litigation, allowance (in Dollars)	$0	$558,000
Preferred stock , shares authorized	100,000,000	'
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	2,000,000,000	600,000,000
Common stock, shares issued	997,299,586	415,462,433
Common stock, shares outstanding	997,299,586	415,462,433
Series A Preferred Stock [Member]	'	'
Preferred stock , par value (in Dollars per share)	$0.00	$0.00
Preferred stock , shares authorized	37	37
Preferred stock, shares issued	35.75	28
Preferred stock, shares outstanding	35.75	28
Series B Preferred Stock [Member]	'	'
Preferred stock , par value (in Dollars per share)	$0.00	$0.00
Preferred stock , shares authorized	63	63
Preferred stock, shares issued	26.13	18.75
Preferred stock, shares outstanding	26.13	18.75

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Revenues	$105,692	$595,506
Cost of services	17,787	5,296
Gross profit	87,905	590,210
Expenses:	'	'
General and administrative	7,289,916	2,195,782
Impairment of technology asset	1,257,058	854,579
Acquisition expense	400,016	0
Bad debt expenses	94,832	477,000
Impairment of goodwill	59,400	0
Depreciation and amortization	14,179	1,168,034
Total Expenses	9,115,401	4,695,395
Loss from operations	-9,027,496	-4,105,185
Other Income/(Expenses):	'	'
Gain/(loss) on change in value - Derivative Warrants	3,157,821	0
Change in fair value of derivatives	0	98,774
Other income - litigation settlement	0	100,000
Income (loss) recognized from debt redemption	-49,672	-42,180
Interest expense	-477,349	-640,445
Financing costs	-848,725	0
Total other income/(expenses)	1,782,075	-483,851
Net loss	($7,245,421)	($4,589,036)
Net loss per share, available to common stockholders (in Dollars per share)	($0.01)	($0.01)
Weighted average number of shares, basic and diluted (in Shares)	711,666,399	360,823,724

CONSOLIDATED_STATEMENT_OF_CHAN

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDER EQUITY (DEFICIT) (USD $)

Stock issued for accrued salary [Member]

Stock issued for accrued salary [Member]

Stock issued for accrued salary [Member]

Stock issued for account payable [Member]

Stock issued for account payable [Member]

Stock issued for account payable [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

HIITS Consulting [Member]

JTJ Capital LLC [Member]

Total

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

HIITS Consulting [Member]

JTJ Capital LLC [Member]

USD ($)

HIITS Consulting [Member]

JTJ Capital LLC [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Balance at Jun. 30, 2011

'

'

'

'

'

'

'

'

'

'

$338,002

'

'

$39,497,941

($43,397,843)

'

'

($3,561,901)

Balance (in Shares) at Jun. 30, 2011

'

'

'

'

'

'

28

18.75

'

'

338,001,527

'

'

'

'

'

'

'

Warrants - derivative liability

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

Issuance of stock in exchange for convertible debentures and accrued interest

'

'

'

'

'

'

'

'

'

'

52,630

'

'

74,265

'

'

'

126,896

Issuance of stock in exchange for convertible debentures and accrued interest (in Shares)

'

'

'

'

'

'

'

'

'

'

52,630,132

'

'

'

'

'

'

'

Issuance of stock for fees/services

'

'

'

'

'

'

'

'

'

'

24,830

'

'

78,838

'

'

'

103,668

Issuance of stock for fees/services (in Shares)

'

'

'

'

'

'

'

'

'

'

24,830,774

'

'

'

'

'

'

'

Net loss

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-4,589,036

'

'

-4,589,036

Balance at Jun. 30, 2012

'

'

'

'

'

'

'

'

'

'

415,462

'

'

39,651,044

-47,986,879

'

'

-7,920,373

Balance (in Shares) at Jun. 30, 2012

'

'

'

'

'

'

28

18.75

'

'

415,462,433

'

'

'

'

'

'

'

Warrants - derivative liability

'

'

'

'

'

'

'

'

'

'

'

'

'

-8,228,882

'

'

'

-8,228,882

Issuance of stock in exchange for assets

'

'

'

'

'

'

'

'

6,000

34,834

'

53,400

1,025,182

'

'

59,400

1,060,016

'

Issuance of stock in exchange for assets (in Shares)

'

'

'

'

'

'

'

'

6,000,000

34,834,156

'

'

'

'

'

'

'

'

Issuance of stock in exchange for acquisition for 100% of the stock of ClariDYS

'

'

'

'

'

'

'

'

'

'

10,526

'

'

410,526

'

'

'

421,053

Issuance of stock in exchange for acquisition for 100% of the stock of ClariDYS (in Shares)

'

'

'

'

'

'

'

'

'

'

10,526,316

'

'

'

'

'

'

'

Issuance of stock in exchange for accrued liability

20,401

166,809

187,210

3,500

101,500

105,000

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of stock in exchange for accrued liability (in Shares)

20,401,250

'

'

3,500,000

'

3,500,000

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of stock in exchange for convertible debentures and accrued interest

'

'

'

'

'

'

'

'

'

'

64,779

'

'

89,435

'

'

'

154,214

Issuance of stock in exchange for convertible debentures and accrued interest (in Shares)

'

'

'

'

'

'

'

'

'

'

64,778,710

'

'

'

'

'

'

'

Issuance of stock for fees/services

'

'

'

'

'

'

'

'

'

'

288,047

'

'

6,295,388

'

'

'

6,583,435

Issuance of stock for fees/services (in Shares)

'

'

'

'

'

'

'

'

'

'

288,046,721

'

'

'

'

'

'

'

Issuance of preferred stock and common stock

'

'

'

'

'

'

'

'

'

'

153,750

'

'

1,880,625

'

'

'

2,034,375

Issuance of preferred stock and common stock (in Shares)

'

'

'

'

'

'

7.75

7.38

'

'

153,750,000

'

'

'

'

'

'

'

Net loss

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-7,245,421

'

'

-7,245,421

Balance at Jun. 30, 2013

'

'

'

'

'

'

'

'

'

'

$997,299

'

'

$41,445,027

($55,232,300)

'

'

($12,789,974)

Balance (in Shares) at Jun. 30, 2013

'

'

'

'

'

'

35.75

26.13

'

'

997,299,586

'

'

'

'

'

'

'

CONSOLIDATED_STATEMENT_OF_CHAN1

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDER EQUITY (DEFICIT) (Parentheticals) (Common Stock [Member])	Jun. 30, 2013
Common Stock [Member]	'
Acquisition of the stock of ClariDYS	100.00%

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flow from operating activities	'	'
Net loss	($7,245,421)	($4,589,036)
Adjustments to reconcile net loss to net cash used in operations	'	'
Depreciation and amortization	14,179	1,168,034
Issuance of stock for services	6,205,995	103,668
Impairment of technology asset and goodwill	1,316,458	854,579
Change in Value of Derivatives	-3,157,821	-155,368
Income/(loss) recognized from debt redemption	49,672	42,180
Bad debt expense	94,832	477,000
Changes in operating assets and liabilities	'	'
Accounts Receivable	25,794	-39,200
Prepaid expenses	0	16,108
Accounts payable - trade and accrued expenses	794,089	1,005,848
Deferred Revenue	0	-182,000
Accrued Interest Payable	255,727	752,346
Cash flow from operating activities	-1,646,496	-545,841
Cash flow from financing activities	'	'
Repayment of notes payable	-150,000	0
Proceeds short term loans	275,326	527,700
Proceeds from issuance of common stock, net of costs	2,034,375	0
Cash flow from financing activities	2,159,701	527,700
Net decrease in cash and cash equivalents	513,205	-18,141
Cash and cash equivalents at beginning of period	67	18,208
Cash and cash equivalents at end of period	513,272	67
Schedule of Noncash Investing and financing Transactions:	'	'
Derivative warrants	8,228,882	0
Exchanged stock for Technology Assets	1,060,016	0
Exchanged stock for Acquisition of stock	421,053	0
Exchanged stock for accounts payable and accrued expenses	292,210	0
Exchanged stock for note payable and accrued interest	154,214	126,896
Exchanged stock for access to independent agents	59,400	0
Stock issued for fees and services	0	103,668
Supplemental information:	'	'
Cash paid for interest	$20,604	$24,630

1_NATURE_OF_OPERATIONS

1. NATURE OF OPERATIONS	12 Months Ended
	Jun. 30, 2013
Disclosure Text Block [Abstract]	'
Nature of Operations [Text Block]	'
	1.             NATURE OF OPERATIONS
	iMedicor, Inc., a Nevada Corporation, formerly doing business as Vemics, Inc. (the “Company”), is a portal-based, virtual network in the healthcare industry. Our focus is twofold: iMedicor, our web-based portal which allows physicians and other healthcare providers to exchange patient specific healthcare information via the internet while maintaining compliance with all Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) regulations, and consulting services that assist physicians obtain funds available through the federal government to convert paper records to digital records via the adoption of Electronic Heath Records management systems.   Our solutions allow physicians to use the internet, to securely, quickly and cost-effectively, exchange and share patient medical information between members of the healthcare community.  Our solutions
	§	Are cloud-based and require no capital investment for equipment or infrastructure
	§	Utilize available real-time communications technologies
	§	Include peripheral or adjunct productivity tools, services and support
	§	Are affordable for medical practices of any size
	§	Are convenient and extendable throughout healthcare organizations (EMRs, Hospitals, HMOs, etc.)
	§	Can be customized to interact within a large number of leading electronic health records systems (EHRs)
	Through the iMedicor portal, physicians will be able to communicate securely with other doctors, sharing HIPAA compliant patient files, records and images, in a secure real-time environment.  The portal can also help doctors use corresponding services from other professionals in the medical industry.

2_GOING_CONCERN

2. GOING CONCERN	12 Months Ended
	Jun. 30, 2013
Going Concern [Abstract]	'
Going Concern [Text Block]	'
	2.             GOING CONCERN
	The Company’s independent registered accounting firm has expressed substantial doubt about the Company’s ability to continue as a going concern as a result of its history of net loss. The Company’s ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans described in this Form 10-K. The outcome of these matters cannot be predicted at this time. These consolidated financial statements do not include any adjustments to the amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue its business.
	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
	The Company has incurred operating losses to date and has an accumulated deficit, total stockholders’ deficit and net working capital deficit of $55,232,300, $12,789,974 and $12,789,974 at June 30, 2013, respectively.  The Company’s activities have been primarily financed through convertible debentures, and private placements of equity securities.  The Company intends to raise additional capital through the issuance of debt or equity securities to fund its operations.  The financing may not be available on terms satisfactory to the Company, if at all.

3_SUMMARY_OF_SIGNIFICANT_ACCOU

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

'

Significant Accounting Policies [Text Block]

'

3.             SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Accounting

The accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.  Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below.

Cash and Cash Equivalents

The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.  As of June 2013, the Company had $125,457 cash amounts that were uninsured.

Concentrations of Credit Risk

The Company has historically provided financial terms to customers in accordance with what management views as industry norms.  Financial terms, for credit–approved customers, are generally on a net 30-61 day basis, though most customers are entitled to a prompt payment discount.  Management periodically and regularly reviews customer account activity in order to assess the adequacy of allowances for doubtful accounts, considering such factors as economic conditions and each customer’s payment history and creditworthiness.  If the financial conditions of our customers were to deteriorate, or if they were otherwise unable to make payments in accordance with management’s expectations, we might have to increase our allowance for doubtful accounts, modify their financial terms and/or pursue alternative collection methods.

Property, Equipment and Depreciation

Property and Equipment are recorded at their historical cost.  Depreciation and amortization are provided by the straight-line method over the useful lives of the assets, which vary from five to seven years.  The cost of repairs and maintenance is charged to operations in the period incurred.

Goodwill and Other Intangible Assets

The Company accounts for goodwill and other intangible assets in accordance with recently issued and adopted accounting pronouncements, which require that goodwill and intangible assets with indefinite useful lives should not be amortized, but instead be tested for impairment at least annually at the reporting unit level.  If impairment exists, a write-down to fair value (normally measured by discounting estimated future cash flows) is recorded.  Intangible assets with finite lives are amortized primarily on a straight-line basis over their estimated useful lives and are reviewed for impairment.

Software Development Costs

We account for software development costs, including costs to develop software products or the software component of products to be marketed to external users, as well as software programs to be used solely to meet our internal needs.

We have determined that technological feasibility for our products to be marketed to external users was reached before the release of those products.  As a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred.  Capitalized costs are amortized based on current and future revenue for each product with an annual minimum equal to the straight-line amortization over the remaining estimated economic life of the product.

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount that the carrying amount of the asset exceeds the fair value of the asset.

Accounting for Derivative Instruments

The Company records all derivatives on the balance sheet at fair value. As at June 30, 2013, the derivative liability consisted of warrants issued by the Company which are deemed derivative instruments as the Company does not have sufficient authorized and unissued common stock to settle all common stock contracts outstanding during the periods to which the derivatives are outstanding. The derivative liability at June 30, 2013 was valued using the Black Scholes Merton valuation model with the following estimates used significant inputs:

Exercise Price

0.01

–

0.5

Term

0.07

–

3.25 years

Volatility

70.65

%

–

299.63

%

Risk Free Rate of Return

0.02

%

–

0.66

%

The derivatives at June 30, 2012 included embedded derivatives deriving from the Company’s Asher notes issued in 2010, which had variable conversion rates based on market prices and reset provisions to the exercise price and conversion price if the Company issued equity or other derivatives at a price less than the exercise price set forth in the notes.  Since the Asher notes converted at a percent of market, there was an indeterminable number of shares that could be issued upon conversion.

Fair Value of Financial Instruments

The recorded value of other financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts payable and accrued expenses approximate the fair value of the respective assets and liabilities at June 30, 2013 and 2012 based upon the short-term nature of the assets and liabilities.

Fair Value Measurements

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements.  To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels.  The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3

Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets and liabilities are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies, valuation models such as the Black Scholes or lattice models or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The Company’s Level 3 financial liabilities consist of the derivative financial instruments for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.  The Company valued the warrant derivatives using Black Scholes Merton valuation models. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future volatility. The Company used Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities; revalued its derivative liability at every reporting period; and recognized gains or losses in the Statements of Operations are attributable to the change in the fair value of the derivative liability.  The derivative conversion feature liability at June 30, 2012 arose from the terms of the Asher notes.  The last of the Asher notes were converted to equity on September 6, 2012.  Accordingly there were no derivative asset or liability balances after that date.

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities – Derivative Financial Instruments

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative liability at every reporting period and recognizes gains or losses in the Statements of Operations that are attributable to the change in the fair value of the derivative liability.

Summary of Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Fair Value Measurement Using

30-Jun-13

Carrying Value

Level 1

Level 2

Level 3

Total

Derivative conversion feature liability

$

-

$

-

$

-

$

-

$

-

Derivative warrant liability

5,999,435

5,999,435

5,999,435

Fair Value Measurement Using

30-Jun-12

Carrying Value

Level 1

Level 2

Level 3

Total

Derivative conversion feature liability

$

920,427

$

$

$

920,427

$

920,427

Derivative warrant liability

7,947

-

-

7,947

7,947

Lattice Valuation Model

The Asher conversion features, Preferred A and B shares and warrants are valued using a lattice valuation model. The lattice model values these instruments based on a probability weighted discounted cash flow model. The Company uses the model to develop a set of potential scenarios. Probabilities of each scenario occurring during the remaining term of the debentures are determined based on management's projections. These probabilities are used to create a cash flow projection over the term of the instruments and determine the probability that the projected cash flow will be achieved. A discounted weighted average cash flow for each scenario is then calculated and compared to the discounted cash flow of the instruments without the compound embedded derivative in order to determine a value for the compound embedded derivative.

Income Taxes

The Company follows the asset and liability approach to accounting for income taxes.  Under this method, deferred tax assets and liabilities are measured based on differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse.  Valuation allowances are established when it is necessary to reduce deferred income tax assets to the amount, if any, expected to be realized in future years.

ASC 740, Accounting for Income taxes (‘ASC 740’), requires that deferred tax assets be evaluated for future realization and reduced by a valuation allowance to the extent we believe a portion more likely than not will not be realized.  We consider many factors when assessing the likelihood of future realization of our deferred tax assets, including our recent cumulative loss experience and expectations of future taxable income by taxing jurisdictions, the carry-forwarding periods available to us for tax reporting purposes and other relevant factors.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Subsequent Events

The Company has evaluated subsequent events through the date when the financial statements were available to be issued (See Note 15).

Revenue recognition

Maintenance or monitoring revenue that is bundled with an initial license fee is deferred and recognized ratably over the contract period.  We have established guidelines on all undeliverable elements of the user license and software arrangements, which consist of maintenance, monitoring and, at times, training and consulting.

Allowance for doubtful accounts

We maintain an allowance for doubtful accounts from estimated losses resulting from the potential inability of certain customers to make required future payments on amounts due us.  Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability.  If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required.  In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts.  Allowance for doubtful accounts for Accounts Receivables for the years ended June 30, 2013 and 2012 were $-0- and $47,000, respectively.  In addition, the allowance for doubtful accounts for Accounts Receivables in Litigation for the years ended June 30, 2013 and 2012 were $-0- and $558,000, respectively. Bad debt expense for the years ended June 30, 2013 and 2012 was $94,832 and $477,000, respectively.

Advertising costs

Advertising costs are reported in selling, general and administrative expenses and include advertising, marketing and promotional programs and are charged to expenses in the period or year in which incurred.  Advertising costs for the years ended June 30, 2013 and 2012 were $12,737 and $12,145, respectively.

Recently Issued Accounting Pronouncements

In February 2013, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2013-04, Liabilities (Topic 405), which provides guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements. The guidance requires an entity to measure those obligations as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations.  ASU 2013-04 is effective for fiscal years beginning after December 15, 2013, which is effective for the Company’s first quarter of fiscal year 2015.  We do not believe the adoption of ASU 2013-04 will have a material effect on the Company’s consolidated financial statements.

In February 2013, the FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.  ASU 2013-02 requires disclosure of the amounts reclassified out of each component of accumulated other comprehensive income and into net earnings during the reporting period and is effective for reporting periods beginning after December 15, 2012.  We do not believe the adoption of ASU 2013−02 in the first quarter of fiscal year 2014 will have a material impact on the measurement of net earnings or other comprehensive income.

In December 2011, the FASB issued ASU 2011-11, Disclosures about Offsetting Assets and Liabilities and in January 2013, the FASB issued ASU 2013-01, Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. ASU 2011-11, as clarified, enhances disclosures surrounding offsetting (netting) assets and liabilities. The clarified standard applies to derivatives, repurchase agreements and securities lending transactions and requires companies to disclose gross and net information about financial instruments and derivatives eligible for offset and to disclose financial instruments and derivatives subject to master netting arrangements in financial statements. The clarified standard did not have a material effect on our financial position or results of operations.

In October 2012, the FASB issued ASU 2012-04, Technical Corrections and Improvements, which makes certain technical corrections (i.e., relatively minor corrections and clarifications) and “conforming fair value amendments” to the FASB Accounting Standards Codification (the “Codification”). The corrections and improvements include technical corrections based on feedback on the Codification and conforming amendments primarily related to fair value in areas outside of ASC 820. The amendments affect various Codification topics and apply to all reporting entities within the scope of those topics and became effective for the Company on December 20, 2012.  The adoption of ASU 2012-04 did not have a material effect on our financial position or results of operations.

In July 2012, the FASB issued ASU 2012−02, Intangibles—Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment.  The revised standard is intended to reduce the cost and complexity of testing indefinite-lived intangible assets other than goodwill for impairment. It allows companies to perform a “qualitative” assessment to determine whether further impairment testing of indefinite-lived intangible assets is necessary, similar in approach to the goodwill impairment test.  The amendments are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The adoption of ASU 2012-02 did not have a material effect on our financial position or results of operations.

In December 2011, the FASB issued ASU 2011−12, Comprehensive Income. The amendments in ASU 2011-12 supersede certain pending paragraphs in ASU 2011−05, Presentation of Comprehensive Income to effectively defer only those changes in ASU 2011−05 that relate to the presentation of reclassification adjustments out of accumulated other comprehensive income. The requirement to report comprehensive income either in a single continuous financial statement or in two separate but consecutive financial statements became effective in the first quarter of fiscal 2013.  The adoption of ASU 2011−12 did not impact the measurement of net earnings or other comprehensive income.

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies that are adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position or results of operations upon adoption.

Net earnings (loss) per share

Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period.  Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, shares issuable on exercise of warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive.  All potentially dilutive securities have been excluded from the computation, as their effect is anti-dilutive.  As of June 30, 2013, 35.75 Series A Preferred shares, 26.13 Series B Preferred shares potentially convertible into 961,611,570 common shares and 307,927,667 common stock warrants and 374,512,266 potential shares from convertible debt were excluded from the calculation of dilutive earnings per share.   As of June 30, 2012, 28 Series A Preferred shares, 18.75 Series B Preferred shares and 97,616,000 common stock warrants were excluded from the calculation of dilutive earnings per share.

Stock Based Compensation

The Company accounts for all stock-based payments and awards under the fair value based method. Stock-based payments to non-employees are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The fair value of stock-based payments to non-employees is periodically re-measured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award and in the same manner as if the Company had paid cash instead of paying with or using equity based instruments on an accelerated basis. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable as at the grant date is measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term.

The Company accounts for the granting of share purchase options to employees using the fair value method whereby all awards to employees are recorded at fair value on the date of the grant. Share based awards granted to employees with a performance condition are measured based on the probable outcome of that performance condition during the requisite service period. Such an award with a performance condition is accrued if it is probable that a performance condition will be achieved. Compensation costs for stock-based payments to employees that do not include performance conditions are recognized on a straight-line basis. The fair value of all share purchase options is expensed over their vesting period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital

Stock-based compensation expense recognized for the years ended June 30, 2013 and 2012 was $187,210 and $103,668, respectively. No share purchase options were granted during such years. All previously granted options had been exercisable at the date of grant. The Company’s employee option plan was discontinued on June 6, 2012; all outstanding options had expired.

4_COMMON_STOCK_AND_PREFERRED_S

4. COMMON STOCK AND PREFERRED STOCK

12 Months Ended

Jun. 30, 2013

Stockholders' Equity Note [Abstract]

'

Stockholders' Equity Note Disclosure [Text Block]

'

4.             COMMON STOCK AND PREFERRED STOCK

Common Stock

The Company as of June 30, 2013 and 2012 had a total of 997,299,586 and 415,462,433 shares outstanding, respectively.   On July 27, 2012, the Board of Directors amended the Articles of Incorporation, and a majority of the shareholders approved the amendment, to increase the authorized number of common shares in the Company to 2 billion shares from 600 million.

During the year ended June 30, 2013 the Company issued 7.5 of preferred series A shares, 7.375 of preferred series B shares, 153,750,000 shares of common stock with 71,500,000 attached warrants for $2,034,375.  The warrants were valued at $2,209,593 at a strike price of $.01 expiring in 2 to 5 years.

The Company issued 6,000,000 shares of common stock valued at $59,400 to HITS consulting for services performed (See Note 7 – Consulting Agreement).

The Company issued 34,834,156 shares of common stock valued at $1,060,016 to JTJ Capital, LLC for the acquisition of the assets of NextEMR (See Note 8 – Acquisitions).

The Company issued 10,526,316 shares of common stock valued at $421,053 for all of the shares of ClariDIS (See Note 8 – Acquisitions).

The Company issued 20,401,250 valued at $187,210 as settlement of accrued compensation to the former CEO of the Company (See Note 14 – Commitments and Contingencies).

The Company issued 3,500,000 shares of common stock valued at $105,000 in payment of accounts payable to a third party.

The Company issued 64,778,710 shares of common stock and 2,500,000 warrants for conversion of debt and interest in the amount of $154,214.  The warrants were valued at $54,226 (See description of warrants below).

The Company also issued 100,000,000 shares of common stock valued at $213,944 and 100,000,000 warrants valued at $348,482 as a loan extension fee (See description of warrants below).

The Company issued 104,946,670 shares of common stock and 42,375,000 warrants as finder’s fees. The common stock was valued at $3,058,739 and the warrants were valued at $1,161,572.

The Company issued 83,100,057 shares of common stock for services, acquisition fees, accrued expenses and consulting valued at $3,310,752 (See description of warrants below).

All warrants outstanding as of June 30, 2013 were valued and recorded as a derivative liability as described below.

During the year ended June 30, 2012, the Company issued 52,630,132 common shares for the conversion of $126,896 in debt and interest. The Company issued 24,830,774 common shares for services valued at $103,668.  In addition the Company issued 1,766,667 warrants associated with capital raising activities. The warrants were valued at $52,380.  At June 30, 2013 these warrants were reclassified as a derivative liability.

Preferred Stock

Pursuant to an amendment of the Articles of Incorporation on December 19, 2012, the Company was authorized to issue up to 100,000,000 shares of blank check preferred stock.  There were authorized 37 and 63 shares of Series “A” and “B” preferred stock, respectively, of which 35.75 Series “A” and 26.13 Series “B” shares, respectively, were issued and outstanding as of June 30, 2013 and 28 Series “A” and 18.75 Series “B” shares as of June 30, 2012.  During the year ended June 30, 2013 there were 7.75 shares of Preferred Series A and 7.375 shares of Preferred Series B issued as part of the $2,034,375 raised in conjunction with 153,750,000 common shares issued.  Also as of June 30, 2012, an additional 23.33 Series “B” shares were issuable upon conversion of outstanding convertible debt (See Note 9 – Notes Payable in Default).

Each share of Series “A” Preferred Stock was convertible into a 1% ownership interest in the Company’s common stock on a non-dilutive basis, giving effect to the conversion of all outstanding preferred shares, convertible debt and the exercise of all outstanding common stock purchase warrants, on a post-converted basis.  Each share of Series “A” Preferred Stock bore dividends when, as and if declared by the Board of Directors.  The Series “A” Preferred is senior to the Series “B” Preferred and to the common stock with respect to liquidation.

In the event of any voluntary or involuntary liquidation or winding-up of the Company, holders of Series A Preferred Stock shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders on the basis as though the Series A Preferred Stock had been converted to common stock as described above, provided that no “out-of-the-money” options or warrants shall be deemed to have been exercised in determining the Common Stock equivalent for the Series A Preferred Stock.

Each share of Series “B” Preferred Stock represented a 1% ownership interest in the Company’s common stock, on a non-dilutive basis, giving effect to the conversion of all outstanding preferred shares, convertible debt and the exercise of all outstanding common stock purchase warrants, on a post-converted basis.  Each share of Series “B” Preferred Stock bore dividends when, as and if declared by the Board of Directors.  The Series “B” Preferred is junior to the Series “A” Preferred, but senior to the common stock with respect to liquidation.

In the event of any voluntary or involuntary liquidation or winding-up of the Company, holders of Series B Preferred Stock shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders on the basis as though the Series B Preferred Stock had been converted to common stock as described above, provided that no “out-of-the-money” options or warrants shall be deemed to have been exercised in determining the Common Stock equivalent for the Series B Preferred Stock.  Notwithstanding the foregoing, in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the Company no distribution shall be made to the holders of Series B Preferred Stock until the holders of Series A Preferred Stock shall be entitled to receive and no distribution shall be made to the holders of Common Stock or any other series of Preferred Stock (other than the Series A Preferred Stock) until the holders of Series B Preferred Stock shall have received the maximum distribution to which the holders of Series B Preferred Stock shall be entitled to receive.

Each of the Series A and Series B Preferred Stock has voting rights on all matters coming before the stockholder equal to the number of shares issuable upon conversion of the Series A and Series B Preferred Stock.

Preferred Stock – continued

If declared by Board of Directors, holders of shares of Series B Preferred Stock were entitled to receive dividends on the last day of each March, June, September and December in each year commencing on March 31, 2011.  If declared, dividends were payable in shares of Common Stock on the holders total investment per share of Series B Preferred Stock at an annual variable rate, which decreased from an initial rate of 18% to 14% and then for calendar 2012 and thereafter to 10% on the last day of each March, June, September and December of each year until such time as the Series B Preferred Stock was either converted into shares of Common Stock as provided in the Series B designation or redeemed through the sale, acquisition or merger of the Company resulting from a change of ownership of the Company.

If declared, on each quarterly dividend payment date the holder of each share of Series B Preferred Stock is to receive the following:

1.

That number of shares of Common Stock, rounded to the nearest whole number, equal to the amount of such dividend payment divided by the Agreed Value of a share of Common Stock on such dividend payment date.  For this purpose, the Agreed Value of a share of Common Stock shall be the amount equal to the average of the closing prices of a share of Common Stock as reported on the OTC Bulletin Board for each of the five trading days immediately preceding such dividend payment date.  For example, if the Agreed Value on a Dividend Payment Date is $.10 per share the total number of shares of Common Stock to be issued on such dividend payment date shall be that number equal to the Investment Per Share of Series B Preferred Stock times the annual dividend rate divided by four divided by the Agreed Value.  Regardless of the actual issuance of the stock certificate for the shares of Common Stock, the shares of Common Stock specifically authorized by the board will be deemed issued on the last day of the quarter.

2.

A warrant to purchase that number of shares of Common Stock equal to the number of Dividend Shares issuable on such dividend date, exercisable at an exercise price per share equal to the Agreed Value.

Notwithstanding the foregoing, no dividend was to be declared or paid to the holders of Series B Preferred Stock until the holders of Series A Preferred Stock received all of the dividends to which the holders of Series A Preferred Stock were entitled to receive and no dividend was to be declared or paid to the holders of Common Stock or any other series of Preferred Stock (other than the Series A Preferred Stock) until the holders of Series B Preferred Stock received all of the dividends to which the holders of Series B Preferred Stock were entitled to receive.  No dividends have been issued or declared by the Board of Directors on any shares of preferred stock.

Warrants:

During the years ended June 30, 2013 and 2012, no warrants were exercised.  During the years ended June 30, 2013 and 2012, 6,063,333 and 2,458,334 warrants expired, respectively.

During the years ended June 30, 2013 and 2012, the Company issued 216,375,000 and 1,766,667 warrants, respectively.  The warrants were valued using the Black Scholes Morton Model.

The Company issued warrants as follows for year ended June 30, 2013:

1)

100,000,000 warrants issued due to lender extending loan maturity date.  The warrants were valued at $348,482.

2)

71,500,000 warrants issued in addition to issuance of common stock or preferred stock resulting from raising funds from investors.  The warrants were valued at $2,209,593.

3)

42,375,000 warrants issued as a fee for assisting in fund raising.  The warrants were valued at $1,161,572

4)

2,500,000 warrants issued as a result of note holder converting to common stock.  The warrants were valued at $54,226.

The warrants issued during the year ended June 30, 2013, have a weighted average remaining life of between 0.07 years and 3.25 years and have a weighted average exercise price of between $.01 and $0.40.

The Company issued 1,766,667 warrants for the year ended June 30, 2012 in addition to the issuance of common shares.  The warrants were valued at $52,380.  The 1,766,667 warrants were issued as fees for services and had a weighted average exercise price of $0.237. The warrants issued during the year ended June 30, 2012 are exercisable in a range beginning at $.01 through $0.24 and expire from 0.07 years to 3.25 years.

Summary of the warrants is as follows:

30-Jun-13

30-Jun-12

Weighted

Weighted

Average

Average

Warrants

Exercise Price

Warrants

Exercise Price

Outstanding at beginning of the period

97,616,000

$

0.237

98,307,667

$

0.237

Issued

216,375,000

0.01

1,766,667

0.04

Exercised

-

-

Forfeited

-

-

Expired

(6,063,333

)

(0.06

)

(2,458,334

)

(0.37

)

Outstanding at end of period

307,927,667

0.18

97,616,000

0.24

Exercisable at end of period

307,927,667

$

0.184

97,616,000

0.237

5_PROPERTY_EQUIPMENT_AND_PURCH

5. PROPERTY, EQUIPMENT AND PURCHASED SOFTWARE	12 Months Ended
	Jun. 30, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	5.            PROPERTY, EQUIPMENT AND PURCHASED SOFTWARE
	Equipment and fixed-asset depreciation and amortization expense for the years ended June 30, 2013 and 2012 was $-0- and $-0-, respectively.  The cost and related accumulated depreciation of disposed assets are removed from the applicable accounts and any gain or loss is included in income in the period of disposal. Property, equipment and purchased software are stated at cost and consist of the following:
		June 30,
		2013			2012
	Furniture and fixtures	$	2,600	$	2,600
	Software		72,430		72,430
	Equipment		252,883		252,883
			327,913		327,913
	Less Accumulated Depreciation & Amortization		327,913		327,913
		$	-0-	$	0-

6_TECHNOLOGY_AND_MEDICAL_SOFTW

6. TECHNOLOGY AND MEDICAL SOFTWARE	12 Months Ended
	Jun. 30, 2013
Disclosure Text Block [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	6.             TECHNOLOGY AND MEDICAL SOFTWARE
	The Company had capitalized all acquisition costs associated with the acquisition of NuScribe Inc.  In addition, we have elected to capitalize all related development costs associated with the completion of the iMedicor portal, which was included in the asset purchase of Nuscribe.  The iMedicor Ô portal was launched in late October 2007 and we are amortizing its cost on a straight line basis over 60 months.  Total amortization expenses (exclusive of impairment losses discussed below) were $14,179 and $1,168,034 for the years ended June 30, 2013 and 2012, respectively.  The Company accounts for impairment of technology assets in accordance with accounting pronouncements, which require that technology with finite useful lives should be amortized, but also be tested for impairment.  If impairment exists, a write-down to fair value measured by discounting estimated future cash flows is recorded.  Intangible assets with finite lives are amortized primarily on a straight-line basis over their estimated useful lives and are reviewed for impairment. The Company has evaluated the technology and medical software for impairment as of both fiscal year ends and has determined that the asset was impaired by $854,579 at June 30, 2012 and an additional $1,084,057 at June 30, 2013. The technology related to the portal to which these assets relate has changed considerably since their acquisition and development, resulting in a change in the estimate of remaining cash flows.

7_CONSULTING_AGREEMENT

7. CONSULTING AGREEMENT	12 Months Ended
	Jun. 30, 2013
Constulting Agreement [Abstract]	'
Constulting Agreement [Text Block]	'
	7.            CONSULTING AGREEMENT
	In November 2012, the Company arranged with HITS Consulting and its owner Henry Denis to acquire access to Mr. Denis’ independent agents to increase our ability to execute on the Careington Meaningful Use contract. Mr. Denis is the CEO of that company and agreed to serve as a special consultant to the CEO of iMedicor. The value of the access to the independent agents was recorded as goodwill in the amount of $59,400 based upon the value of the common stock and warrants issued. At June 30, 2013, the goodwill was determined to be fully impaired.
	The consideration for the transaction was six million shares of common stock and six million warrants to purchase common stock, exercisable at $0.02 per share for a three-year period. A 90 day contract was signed after which both parties could re-engage to negotiate, in good faith, an extension with terms to be determined by and agreed upon by both parties. The Company agreed to pay $10,000 in monthly salary for Henry Denis.  On or about June 30, 2013, Henry Denis and his entity HITS Consulting were terminated and not required to provide any further services to the Company.

8_ACQUISITIONS

8. ACQUISITIONS	12 Months Ended
	Jun. 30, 2013
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	8.           ACQUISITIONS
	NextEMR/iPenMD – Software:
	On January 22, 2013, the Company purchased NextEMR (Electronic Medical Record) software with iPenMD software imbedded.  The purpose of the software purchase is its unique electronic Pen features allowing physicians to regain lost productivity during the transition from paper to electronic health records.
	In accordance with the January 22, 2013 asset purchase agreement the Company was required to issue a total of 34,834,156 shares of common stock. The technology asset was valued at $660,000 based upon the fair market value of the stock issued and $400,016 was expensed to acquisition costs.
	As of June 30, 2013, the Technology asset was deemed fully impaired.
	ClariDIS Corporation
	On March 18, 2013, the Company acquired all of the 275,000 outstanding shares of ClariDIS Corporation (a data mining and data aggregation business) in exchange for 10,526,316 common shares of iMedicor Inc. The transaction was valued at $421,053 based upon 10,526,316 of shares exchanged at the stock price of $0.04 on March 18, 2013 the date of closing. The acquisition value in shares was applied entirely to the Technology software asset acquired.  The purpose of the ClariDIS acquisition was intended to strengthen the IT and security encryption capabilities of iMedicor's Social Health Information Exchange (HIE) Version 3.0, the most recent release iMedicor’s information technology exchange.
	As of June 30, 2013, the Technology asset was deemed fully impaired.
	The results of operations of the acquired company ClariDIS Corporation are included in the statement of operations of the combined entity.  Note that the Revenues were $-0- and Expenses totaled $960.

9_NOTES_PAYABLE_IN_DEFAULT

9. NOTES PAYABLE IN DEFAULT	12 Months Ended
	Jun. 30, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	9.             NOTES PAYABLE IN DEFAULT
	Notes payable and accrued interest at June 30, 2013 and 2012 consisted of the following:
		June 30,		June 30,
		2013		2012
	(1) Convertible note bearing interest at 17.98% per annum, as amended due on June 30, 2008, in default, convertible at $1.00 per share or 150,000 common shares at June 30, 2013.	$	150,000	$	150,000
	(2) Convertible note bearing interest at 8% per annum, increased to 22% when defaulted. (See below for variable terms of conversion). These notes were originally $180,000 borrowed and were past due, originally due on varying dates ranging from December 29, 2010 through March 8, 2011.  They have been completely converted to equity as of September 2012.		-		62,450
	(3) Convertible notes bearing interest at 20% per annum with a conversion price of $0.05 per share at June 30, 2013 - past due, originally due on December 30, 2009		306,858		268,066
	(4) Convertible note bearing interest at 10% per annum with a conversion price of $0.05 per share – 1,327,680 shares at June 30, 2013  - past due, originally due on July 26, 2010		66,384		61,342
	(5) Secured convertible note bearing interest at 18%-24% per annum with a conversion into Preferred B series shares at a  price of $125,000 per share, amended on July 1, 2012 and now due on June 30, 2013		1,513,964		1,220,395
	(6) Secured convertible note bearing interest at 8%-18% per annum with a conversion into Preferred B series shares at a price of $125,000 per share. amended on July 1, 2012 and now due on June 30, 2013		1,836,473		1,695,914
	(7) Note executed in May 2002 bearing interest at 8% per annum, originally due in November 2008		370,200		329,086
	(8) Note executed in May 2002 bearing interest at 8% per annum, no maturity date		371,387		365,463
	(9) Three notes executed from September 22, 2009 through January 11, 2011		35,000		75,000
	(10) Note executed in July 2011 bearing interest at 18%, maturity extended to August 23, 2013		170,095		161,920
	Total notes payable, all deemed current, due to various defaults as discussed below	$	4,820,361	$	4,389,636
	(1) 17.98% - Hospice convertible debenture – Originally due on September 30, 2004.  The note has been revised to accrue interest of $50,000 through September 30, 2004, the original due date.  The effective interest rate is 17.98%.  The debenture was to begin to be paid in January 2007 over a period of 18 months at a monthly amount of $8,333. The bondholder had agreed to no additional interest beyond September 30, 2004.  The Company is in breach of this agreement as of January 2007 and thereafter as a result of not making payments and is in default. The Company has not received a response from the note holder regarding a settlement proposal.  This note is unsecured and continues in default.
	(2) Asher convertible notes payable, with interest at 8%, which increased to 22% upon default of payment, were converted to equity by September 6, 2012.  These notes, consisting of principal and accrued interest of $45,000 and $17,450, respectively, at June 30, 2012 were converted into 60,778,706 of common shares in September 2012.  The shares issued for the year ended June 30, 2012 for the conversions from debt to equity was 52,630,130.  The conversion price was variable and equal to 58% multiplied by the market price, representing a 42% discount).  The market price was defined as the average of the lowest three trading prices for the common stock during the 10 trading days prior to the conversion date. Interest expense was $20,549 in 2013 was and $8,843 in 2012.
	(3) Schneller convertible notes payable originated on December 23, 2008 with a loan of $100,000 with a maturity date of December 31, 2009. If the loan was not repaid by the designated date there was a loan redemption fee of $50,000.  The $100,000 bears interest at 20%. The accrued interest payable was $156,858 and $118,066 for June 30, 2013 and 2012, respectively.  Interest expense was $38,792 and $38,792 for the years ended June 30, 2013 and 2012.  The Company is in default on this note as of December 31, 2009 and thereafter.  This note is unsecured.  Mr. Schneller has been appointed to the Board of Directors post June 30, 2013 and the audit committee.  Since this note has been in default the Company has been accruing financing costs that reflect the value of common shares and warrants every 90 days that this note remains in default.  The note holder earns every 90 days of default 2,672,000 of common shares and 2,672,000 warrants that are being recorded based on the stock value.  As of June 30, 2013, there were 36,072,000 of common shares and 36,072,000 of warrants to purchase common stock (warrants have a 5 year term and a $.01 exercise price). The value of the accrued financing costs for the of 36,072,000 common shares and 36,072,000 warrants as of June 30, 2013 was $638,786.
	(4) Koeting convertible note payable, with interest at 10%, originated on March 26, 2010 with a loan to the Company of $50,000 payable on July 26, 2010. There was accrued interest payable at June 30, 2013 and 2012 of $16,383 and $11,342, respectively.  The Company is in default on this note as of July 26, 2010 and thereafter.  The Company has sought an extension and has not received a response. This note is unsecured.  Interest expense for the years ended June 30, 2013 and 2012 was $5,041 and $5,041, respectively.
	(5) The note amount of $1,074,450 was lent by Sonoran Pacific Resources (a related party to a shareholder who has significant ownership in the Company and an interest in this entity) over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $439,514 at June 30, 2013 for a total note balance at such date of $1,513,964.  There was accrued interest payable of $286,196 at June 30, 2012 for a total note balance at such date of $1,220,395. As of July 1, 2012, an amended and restated loan agreement was signed which stated that the note was deemed not in default.  Interest rates have been 18% from September 15, 2010 to May 31, 2011, 20% from June 1, 2011 to June 30, 2011 and 24% from July 1, 2011 to June 30, 2012.  The interest rate from July 1, 2012 to June 30, 2013 will be at 10% and will increase to 12% if the note is extended, at the Company’s option, beyond June 30, 2013.  If the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. As part of the amended loan agreement the note was extended to June 30, 2014 Also, the Company issued 50 million common shares as part of a prior commitment dated June 2, 2011and agreed to issue an additional 50,000,000 shares relating to the July 1, amended and restated loan agreement.  In addition, the agreement includes an issue of 100,000,000 warrants at an exercise price of $.01, expiring in four years.  This note and the one described below in (6) are convertible into Preferred B stock at $125,000 per share based on the total outstanding note balances at the dates of conversion.  This note is secured by all assets of the Company.
	(6) The note amount of $1,190,457 was also lent by Sonoran Pacific Resources over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $646,016 at June 30, 2013 for a total note balance at such date of $1,836,473.  There was accrued interest payable of $505,457 at June 30, 2012 for a total note balance at such date of $1,695,914. There was a Replacement Secured Convertible Promissory Note in the original amount of $1,395,452 having an original date of April 17, 2010 and a Replacement Date of January 1, 2011.  As of July 1, 2012, an amended loan agreement was signed that the note was deemed not in default. Interest rates were 8% from 1/1/11 to 9/30/11 and 18% from October 1, 2011 to June 30, 2012.  The interest rate from July 1, 2012 to June 30, 2013is10% and will increase to 12% if the note is extended as set forth for the note detailed above.   Similarly, if the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. The interest expense was $140,559 and $306,426 for the years ended June 30, 2013 and 2012, respectively.  This note is secured by all assets of the Company.
	The above convertible notes are convertible into an aggregate of 23.33 shares of Series “B” preferred stock. (See Note 4).
	(7) On October 20, 2005, the Company agreed to repurchase shares of several shareholders referred to as the Wellbrock Group; the shares were exchanged for a $300,000 three-year note to be amortized over ten years at 8%.  The shares of stock are held in escrow until the notes are completely paid.  If there are any late payments per the payment schedule, the shares are to be released from escrow and to revert back to the original shareholders.  As of September 30, 2007 and June 30, 2007 the amounts owed were $293,199 and $298,188, respectively. The first ten monthly payments of principal and interest were to be in installments of $1,000 and the remaining 26 payments were to be in installments of $3,640.  The balloon payment of $272,076 was due on November 1, 2008.  The balloon balance was subsequently paid down to $263,492, but no further payments were made. The Company continues to be in default on this note.  The Company has sought an extension/modification and has not received a response.  The Company continues to accrue interest at 8%.  The accrued interest payable was $106,708 and $65,595 at June 30, 2013 and 2012, respectively.  The total note balances at such dates were $370,200 and $329,086, respectively. Interest expense for the years then ended was $41,114 in 2013 and $21,254 in 2012.
	(8) One of the Company’s former directors has lent funds in varying amounts beginning November 5, 2010.  Outstanding principal totals were $271,693 and $344,576 at June 30, 2013 and 2012, respectively. Interest payable accrued at 8% totaled of $299,694 and $20,887 at such dates for total balances outstanding of $371,387 and $365,463, respectively. There is no maturity. Interest expense was $78,807 and $34,994, respectively for the years ending June 30, 2013 and 2012.
	(9) There were three and four notes payable totaling $35,000 and $75,000 and were unsecured as of June 30, 2013 and 2012, respectively. In November 2012, $40,000 of debt plus accrued interest of $31,250 was converted into 4 million shares of common stock. The amounts were lent on various dates and are all non-interest bearing. The Company is in default on these notes and has sought an extension, but has not received a response these lenders.
	(10) Genesis Finance Corporation loaned the Company $155,000 during fiscal 2012. The note accrues interest at 18%.  The note was being paid in installments of $2,325 on the 25th of each month.  On August 26, 2012 an amended promissory note extended the maturity date to February 27, 2013. On January 30, 2013 there was an additional extension of six months to August 23, 2013.  The Company agreed to pay a 2% extension fee in the amount of $3,100 upon signing and to deposit $6,975 to be used to make monthly payments for March, April and May 2013. In connection with the debt extensions, the Company agreed to issue an aggregate of 1,000,000 shares to Genesis, which shares were issued subsequently.  ).  This note is guaranteed by Sonoran Pacific Resources.  Accrued interest expense was $20,150 and $6,920 at June 30, 2013 and June 30, 2012, respectively.

10_DERIVATIVE_LIABILITIES

10. DERIVATIVE LIABILITIES	12 Months Ended
	Jun. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Instruments and Hedging Activities Disclosure [Text Block]	'
	10.             DERIVATIVE LIABILITIES
	The Company’s Asher Notes issued in 2010 had variable conversion rates and reset provisions to the conversion price if the Company issued equity or other derivatives at a price less than the conversion price as set forth in such notes. These features resulted in a derivative liability in our financial statements.  In addition, due to the indeterminate number of shares to be issued upon conversion of the Asher Notes, the outstanding warrants and preferred shares became tainted derivatives since they may not be equity settled.  The Asher Notes were converted to equity during the year ending June 30, 2013.
	The Company has equity equivalents outstanding that exceed its authorized shares. The Company’s outstanding warrants have been reclassified to a liability as of March 31, 2013 in the amount of $8,228,882, the date the equity equivalents exceeded authorized shares.
	Our derivative liabilities increased to $5,999,435 at June 30, 2013 from $928,374 at June 30, 2012.
	The following tabular presentation reflects the components of derivative financial instruments on the Company’s balance sheet at June 30, 2013 and 2012 and provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended June 30, 2013:
		JUNE 30,
		2013			2012
	Tainted warrants and Preferred shares	$	-0-		$	755,085
	Warrants in excess of authorized shares		5,999,435			-0-
	Embedded conversion features – Asher Notes		-0-			173,289
	Total	$	5,999,435		$	928,374
	Reconciliation in Change of Level 3 Values
	Beginning Balance	$	928,374		$	980,568
	Gain/(loss) on change in value-Derivative Warrants		5,999,435			-0-
	Income (loss) recognized from debt redemption		(49,672	)		(42,180	)
	Change in Derivative Liability – Conversion		(878,702	)		(10,014	)
	Ending Balance	$	5,999,435		$	928,374

11_INCOME_TAXES

11. INCOME TAXES	12 Months Ended
	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	11.             INCOME TAXES
	The Company sustained taxable losses of approximately $10,600,000 and $4,600,000 for the fiscal years ended June 30, 2013 and 2012, respectively. At such dates it had federal net operating loss carry-forwards of approximately $47,000,000 and $36,100,000, respectively, which at the latter date may be carried forward for tax years ending through June 30, 2033. Utilization of NOL carry-forwards may be limited under various sections of the Internal Revenue Code depending on the nature of the Company’s operations. The Company’s income tax returns for tax years subsequent to 2008 are subject to examination by the Internal Revenue Service and applicable state taxing authorities.
	Deferred tax assets comprise the following at June 30, 2013 and June 30, 2012, respectively.
		June 30,
		2013			2012
	Deferred Income Tax Assets	$	15,879,453		$	12,270,894
	Valuation Allowance		(15,879,453	)		(12,270,894	)
	Net Deferred Tax Asset	$	-0-		$	-0-
	Reconciliation of the effective income tax rate to the federal statutory rate:
	Federal income tax rate		34	%		34	%
	Change in valuation allowance on net operating loss carry-forwards		(34.0	)		(34.0	)
	Effective income tax rate		0	%		0	%

12_CONCENTRATION_OF_CREDIT_RIS

12. CONCENTRATION OF CREDIT RISK	12 Months Ended
	Jun. 30, 2013
Risks and Uncertainties [Abstract]	'
Concentration Risk Disclosure [Text Block]	'
	12.           CONCENTRATION OF CREDIT RISK
	Customers and Credit Concentrations
	Revenue concentrations for the year ended June 30, 2013 and 2012 and the accounts receivables concentrations at June 30, 2013 and 2012 are as follows:
		Net Sales for the Year Ended						Accounts receivable At
		June 30,			June 30,			June 30,			June 30,
		2013			2012			2013			2012
	Customer A		52.5	%		43.3	%		0	%		0	%
	Customer B		18.1	%		20.1			0	%		0	%
													%
			70.6	%		63.4	%		0	%		0	%
	A reduction in sales from or loss of such customers would have a material adverse effect on the Company’s results of operations and financial condition.

13_INCOME_AND_BAD_DEBTS

13. INCOME AND BAD DEBTS	12 Months Ended
	Jun. 30, 2013
Income And Bad Debts [Abstract]	'
Income And Bad Debts [Text Block]	'
	13.           INCOME AND BAD DEBTS
	The Company had recorded income in the year ended June 30, 2012for a settlement  from Mass Mutual Insurance in the amount of $260,000 and a receivable balance carried into the year ended June 30, 2013 of $62,000 that was written off to bad debt.  The Company recorded revenue and related account receivable of $26,280 for Access Health., The Company wrote off $26,280 in the year ended June 30, 2013.  The Company lost in legal cases against the two aforementioned companies.  Thus, the Company has written off all related receivables associated with these entities.

14_COMMITMENTS_AND_CONTINGENCI

14. COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Jun. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	14.           COMMITMENTS AND CONTINGENCIES
	(A)         LITIGATION
	In the normal course of business, the Company is involved in lawsuits and claims.  While the amounts claimed could be material, the ultimate liability cannot now be determined because of the considerable uncertainties that exist.  Therefore, it is possible that the results of operations or liquidity in a particular period could be affected by certain contingencies.  However, based on facts currently available, management believes that the outcome of these lawsuits and claims will not have a material adverse effect on the Company’s financial position.
	We follow applicable accounting guidance to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss but which will only be resolved when one or more future events occur or fail to occur.  We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment.  In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.
	If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is accrued in our financial statements.  If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, is disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.
	In a lawsuit filed in April of 2013, Carpathia Holdings claims that iMedicor is liable for service fees associated with hosting services provided by the plaintiff between April 2011 and July 2011.  The plaintiff is a hosting company.  Present management believes that the amount of the lawsuit far exceeds any comparable reasonable market prices for such services if, in fact such services were used by iMedicor.  iMedicor denies that it definitively owes any amount and will vigorously defend itself in court.  iMedicor has thus not accrued a reserve associated with this legal action.
	In 2007 iMedicor acquired the assets of NuScribe which had leased a piece of mailing equipment but had failed to pay all amounts due under the lease.  Neoposte, now doing business as Mail Finance, Inc., is the company that leased the equipment to NuScribe. Mail Finance filed suit in March 2013 to recoup the unpaid amounts under the lease.  Because iMedicor acquired the assets of NuScribe in 2007 but did not acquire any liabilities of NuScribe, management believes that iMedicor has no liability for the unpaid amounts under the lease.  iMedicor intends to vigorously contest the lawsuit on the grounds that it has no liability for the amounts claimed.
	A lawsuit was filed in December 2011 in New York by Mainstreet Commercial Group, LLC. (“Mainstreet”)  Mainstreet purports to have provided merger and acquisition services for iMedicor in 2006.  The company claims that it was not compensated for work it claims to have done associated with an acquisition.  Subsequent to the close of the quarter an attorney for the Plaintiff has suggest a settlement for substantially less than the initial action.  Present management is considering the offer of settlement in advance of a prospective arbitration hearing although has not concluded that any compensation was withheld.  Management does not consider the likelihood of any settlement, if that is what management decides is in the best interest of the company, to be material and has thus not recorded a reserve relating to this issue.
	(B) LACK OF INSURANCE
	As of June 30, 2012 the Company has no insurance policies in place.  Through the date the consolidated financial statements were available to be issued, the Company has not been advised of liability or other claims made against it.
	The Company secured Workers Compensation policies as of February 2, 2013, commercial insurances as of February 2, 2013 and Director’s and Officers’ insurance as of April 23, 2013
	(C) LEASE COMMITMENTS
	The Company does not have a formal business address; as a result there are no rent commitments.  The Company signed a lease commencing November 15, 2013 for its new location in Windermere, FL.
	(D) LIABILITIES TO CONSULTANTS
	The Company has significant liabilities owed to various outside consultants who nevertheless continue to provide services to the Company.  Company owes approximately $703,531 of accrued payroll and 1099 contractor fees as of June 30, 2013.
	(E) RECLASSIFICATION OF EMPLOYEE/CONSULTANT STATUS OF CHIEF EXECUTIVE OFFICER
	The Company has recently received approval from the Internal Revenue Service as a Voluntary Classification Settlement Program which absolves the Company from having to report the CEO Fred Zolla as an employee for the past 3 years, 2010 – 2012.  Fred Zolla began being reported as an employee commencing January 1, 2013.
	(G) EMPLOYMENT AGREEMENT WITH CHIEF EXECUTIVE OFFICER
	The Company and Mr. Fred Zolla, its Chief Executive Officer and Chairman of the Board, entered into a three-year employment agreement effective as of October 1, 2004, pursuant to which Mr. Zolla was paid an annual salary (based on a calendar year) of $70,000 in 2005, $130,000 in 2006 and $168,000 for 2007.  The Agreement provided for 18 months of severance in the event of termination without cause.  Mr. Zolla's initial agreement expired on December 31, 2007 and was renewed for a period of two years, expiring December 31, 2009, with annual renewal thereafter unless terminated. The Company has recorded base annual compensation for Mr. Zolla of $144,000.  Mr. Zolla has not received full compensation under the contract expired and is owed $157,210 at June 30, 2012, which amount is reflected in the accompanying financial statements. At June 30, 2013 the Company issued Mr. Zolla 20,401,250 common shares valued at $187,210 as compensation.

15_SUBSEQUENT_EVENTS

15. SUBSEQUENT EVENTS	12 Months Ended
	Jun. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	15.           SUBSEQUENT EVENTS
	The Company has evaluated subsequent events from the balance sheet date through the date the accompanying financial statements were available to be issued and has found the following material events to report.
	The Company has raised $656,250 subsequent to June 30, 2013 and issued 36 million common shares, 4.75 Preferred Series B shares and 12.5 million warrants to purchase common shares for these funds.  The warrants have an exercise price of $.01 with expiration dates ranging between 18 to 24 months from date of issue.
	In addition, the Company has issued another 19,312,500 of common shares as fees for services during that period, which were valued at $634,250.
	The Company and Mr. Fred H. Zolla mutually agreed to terminate Mr. Zolla’s employment by the Company as Executive Chairman of the Board of the Company, effective as of the close of business on November 18, 2013.  Mr. Zolla also resigned as a Director of the Company, effective as of the close of business on November 18, 2013.  In conjunction with Mr. Zolla’s departure from the Company, the Company will retain Mr. Zolla as a consultant to the Company upon terms and conditions being negotiated between Mr. Zolla and the Company.
	On December 3, 2013, iMedicor, Inc., dismissed Demetrius Berkower, LLC ("Demetrius") as the independent accountant to audit the financial statements of the Company, effective as of that date.  Previously, the Audit Committee of the Board of Directors of the Company had authorized and approved the dismissal of Demetrius.
	On December 3, 2013, the Company engaged PMB Helin Donovan ("PMB") as the independent accountant to audit the financial statements of the Company and its subsidiaries effective as of that date.  Previously, the Audit Committee of the Board of Directors of the Company authorized and approved the engagement of PMB.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)

12 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

'

Basis of Accounting, Policy [Policy Text Block]

'

Basis of Accounting

The accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.  Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below.

Cash and Cash Equivalents, Policy [Policy Text Block]

'

Cash and Cash Equivalents

The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.  As of June 2013, the Company had $125,457 cash amounts that were uninsured

Concentration Risk, Credit Risk, Policy [Policy Text Block]

'

Concentrations of Credit Risk

The Company has historically provided financial terms to customers in accordance with what management views as industry norms.  Financial terms, for credit–approved customers, are generally on a net 30-61 day basis, though most customers are entitled to a prompt payment discount.  Management periodically and regularly reviews customer account activity in order to assess the adequacy of allowances for doubtful accounts, considering such factors as economic conditions and each customer’s payment history and creditworthiness.  If the financial conditions of our customers were to deteriorate, or if they were otherwise unable to make payments in accordance with management’s expectations, we might have to increase our allowance for doubtful accounts, modify their financial terms and/or pursue alternative collection methods.

Property, Plant and Equipment, Policy [Policy Text Block]

'

Property, Equipment and Depreciation

Property and Equipment are recorded at their historical cost.  Depreciation and amortization are provided by the straight-line method over the useful lives of the assets, which vary from five to seven years.  The cost of repairs and maintenance is charged to operations in the period incurred.

Goodwill and Intangible Assets, Policy [Policy Text Block]

'

Goodwill and Other Intangible Assets

The Company accounts for goodwill and other intangible assets in accordance with recently issued and adopted accounting pronouncements, which require that goodwill and intangible assets with indefinite useful lives should not be amortized, but instead be tested for impairment at least annually at the reporting unit level.  If impairment exists, a write-down to fair value (normally measured by discounting estimated future cash flows) is recorded.  Intangible assets with finite lives are amortized primarily on a straight-line basis over their estimated useful lives and are reviewed for impairment.

Internal Use Software, Policy [Policy Text Block]

'

Software Development Costs

We account for software development costs, including costs to develop software products or the software component of products to be marketed to external users, as well as software programs to be used solely to meet our internal needs.

We have determined that technological feasibility for our products to be marketed to external users was reached before the release of those products.  As a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred.  Capitalized costs are amortized based on current and future revenue for each product with an annual minimum equal to the straight-line amortization over the remaining estimated economic life of the product.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

'

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount that the carrying amount of the asset exceeds the fair value of the asset.

Derivatives, Policy [Policy Text Block]

'

Accounting for Derivative Instruments

The Company records all derivatives on the balance sheet at fair value. As at June 30, 2013, the derivative liability consisted of warrants issued by the Company which are deemed derivative instruments as the Company does not have sufficient authorized and unissued common stock to settle all common stock contracts outstanding during the periods to which the derivatives are outstanding. The derivative liability at June 30, 2013 was valued using the Black Scholes Merton valuation model with the following estimates used significant inputs:

Exercise Price

0.01

–

0.5

Term

0.07

–

3.25 years

Volatility

70.65

%

–

299.63

%

Risk Free Rate of Return

0.02

%

–

0.66

%

The derivatives at June 30, 2012 included embedded derivatives deriving from the Company’s Asher notes issued in 2010, which had variable conversion rates based on market prices and reset provisions to the exercise price and conversion price if the Company issued equity or other derivatives at a price less than the exercise price set forth in the notes.  Since the Asher notes converted at a percent of market, there was an indeterminable number of shares that could be issued upon conversion.

Fair Value of Financial Instruments, Policy [Policy Text Block]

'

Fair Value of Financial Instruments

The recorded value of other financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts payable and accrued expenses approximate the fair value of the respective assets and liabilities at June 30, 2013 and 2012 based upon the short-term nature of the assets and liabilities.

Fair Value Measurement, Policy [Policy Text Block]

'

Fair Value Measurements

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements.  To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels.  The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3

Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets and liabilities are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies, valuation models such as the Black Scholes or lattice models or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The Company’s Level 3 financial liabilities consist of the derivative financial instruments for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.  The Company valued the warrant derivatives using Black Scholes Merton valuation models. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future volatility. The Company used Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities; revalued its derivative liability at every reporting period; and recognized gains or losses in the Statements of Operations are attributable to the change in the fair value of the derivative liability.  The derivative conversion feature liability at June 30, 2012 arose from the terms of the Asher notes.  The last of the Asher notes were converted to equity on September 6, 2012.  Accordingly there were no derivative asset or liability balances after that date.

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities – Derivative Financial Instruments

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative liability at every reporting period and recognizes gains or losses in the Statements of Operations that are attributable to the change in the fair value of the derivative liability.

Summary of Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Fair Value Measurement Using

30-Jun-13

Carrying Value

Level 1

Level 2

Level 3

Total

Derivative conversion feature liability

$

-

$

-

$

-

$

-

$

-

Derivative warrant liability

5,999,435

5,999,435

5,999,435

Fair Value Measurement Using

30-Jun-12

Carrying Value

Level 1

Level 2

Level 3

Total

Derivative conversion feature liability

$

920,427

$

$

$

920,427

$

920,427

Derivative warrant liability

7,947

-

-

7,947

7,947

Lattice Valuation Model

The Asher conversion features, Preferred A and B shares and warrants are valued using a lattice valuation model. The lattice model values these instruments based on a probability weighted discounted cash flow model. The Company uses the model to develop a set of potential scenarios. Probabilities of each scenario occurring during the remaining term of the debentures are determined based on management's projections. These probabilities are used to create a cash flow projection over the term of the instruments and determine the probability that the projected cash flow will be achieved. A discounted weighted average cash flow for each scenario is then calculated and compared to the discounted cash flow of the instruments without the compound embedded derivative in order to determine a value for the compound embedded derivative.

Income Tax, Policy [Policy Text Block]

'

Income Taxes

The Company follows the asset and liability approach to accounting for income taxes.  Under this method, deferred tax assets and liabilities are measured based on differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse.  Valuation allowances are established when it is necessary to reduce deferred income tax assets to the amount, if any, expected to be realized in future years.

ASC 740, Accounting for Income taxes (‘ASC 740’), requires that deferred tax assets be evaluated for future realization and reduced by a valuation allowance to the extent we believe a portion more likely than not will not be realized.  We consider many factors when assessing the likelihood of future realization of our deferred tax assets, including our recent cumulative loss experience and expectations of future taxable income by taxing jurisdictions, the carry-forwarding periods available to us for tax reporting purposes and other relevant factors.

Use of Estimates, Policy [Policy Text Block]

'

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Subsequent Events, Policy [Policy Text Block]

'

Subsequent Events

The Company has evaluated subsequent events through the date when the financial statements were available to be issued (See Note 15).

Revenue Recognition, Policy [Policy Text Block]

'

Revenue recognition

Maintenance or monitoring revenue that is bundled with an initial license fee is deferred and recognized ratably over the contract period.  We have established guidelines on all undeliverable elements of the user license and software arrangements, which consist of maintenance, monitoring and, at times, training and consulting.

Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]

'

Allowance for doubtful accounts

We maintain an allowance for doubtful accounts from estimated losses resulting from the potential inability of certain customers to make required future payments on amounts due us.  Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability.  If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required.  In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts.  Allowance for doubtful accounts for Accounts Receivables for the years ended June 30, 2013 and 2012 were $-0- and $47,000, respectively.  In addition, the allowance for doubtful accounts for Accounts Receivables in Litigation for the years ended June 30, 2013 and 2012 were $-0- and $558,000, respectively. Bad debt expense for the years ended June 30, 2013 and 2012 was $94,832 and $477,000, respectively.

Advertising Costs, Policy [Policy Text Block]

'

Advertising costs

Advertising costs are reported in selling, general and administrative expenses and include advertising, marketing and promotional programs and are charged to expenses in the period or year in which incurred.  Advertising costs for the years ended June 30, 2013 and 2012 were $12,737 and $12,145, respectively.

New Accounting Pronouncements, Policy [Policy Text Block]

'

Recently Issued Accounting Pronouncements

In February 2013, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2013-04, Liabilities (Topic 405), which provides guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements. The guidance requires an entity to measure those obligations as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations.  ASU 2013-04 is effective for fiscal years beginning after December 15, 2013, which is effective for the Company’s first quarter of fiscal year 2015.  We do not believe the adoption of ASU 2013-04 will have a material effect on the Company’s consolidated financial statements.

In February 2013, the FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.  ASU 2013-02 requires disclosure of the amounts reclassified out of each component of accumulated other comprehensive income and into net earnings during the reporting period and is effective for reporting periods beginning after December 15, 2012.  We do not believe the adoption of ASU 2013−02 in the first quarter of fiscal year 2014 will have a material impact on the measurement of net earnings or other comprehensive income.

In December 2011, the FASB issued ASU 2011-11, Disclosures about Offsetting Assets and Liabilities and in January 2013, the FASB issued ASU 2013-01, Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. ASU 2011-11, as clarified, enhances disclosures surrounding offsetting (netting) assets and liabilities. The clarified standard applies to derivatives, repurchase agreements and securities lending transactions and requires companies to disclose gross and net information about financial instruments and derivatives eligible for offset and to disclose financial instruments and derivatives subject to master netting arrangements in financial statements. The clarified standard did not have a material effect on our financial position or results of operations.

In October 2012, the FASB issued ASU 2012-04, Technical Corrections and Improvements, which makes certain technical corrections (i.e., relatively minor corrections and clarifications) and “conforming fair value amendments” to the FASB Accounting Standards Codification (the “Codification”). The corrections and improvements include technical corrections based on feedback on the Codification and conforming amendments primarily related to fair value in areas outside of ASC 820. The amendments affect various Codification topics and apply to all reporting entities within the scope of those topics and became effective for the Company on December 20, 2012.  The adoption of ASU 2012-04 did not have a material effect on our financial position or results of operations.

In July 2012, the FASB issued ASU 2012−02, Intangibles—Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment.  The revised standard is intended to reduce the cost and complexity of testing indefinite-lived intangible assets other than goodwill for impairment. It allows companies to perform a “qualitative” assessment to determine whether further impairment testing of indefinite-lived intangible assets is necessary, similar in approach to the goodwill impairment test.  The amendments are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The adoption of ASU 2012-02 did not have a material effect on our financial position or results of operations.

In December 2011, the FASB issued ASU 2011−12, Comprehensive Income. The amendments in ASU 2011-12 supersede certain pending paragraphs in ASU 2011−05, Presentation of Comprehensive Income to effectively defer only those changes in ASU 2011−05 that relate to the presentation of reclassification adjustments out of accumulated other comprehensive income. The requirement to report comprehensive income either in a single continuous financial statement or in two separate but consecutive financial statements became effective in the first quarter of fiscal 2013.  The adoption of ASU 2011−12 did not impact the measurement of net earnings or other comprehensive income.

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies that are adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position or results of operations upon adoption.

Earnings Per Share, Policy [Policy Text Block]

'

Net earnings (loss) per share

Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period.  Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, shares issuable on exercise of warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive.  All potentially dilutive securities have been excluded from the computation, as their effect is anti-dilutive.  As of June 30, 2013, 35.75 Series A Preferred shares, 26.13 Series B Preferred shares potentially convertible into 961,611,570 common shares and 307,927,667 common stock warrants and 374,512,266 potential shares from convertible debt were excluded from the calculation of dilutive earnings per share.   As of June 30, 2012, 28 Series A Preferred shares, 18.75 Series B Preferred shares and 97,616,000 common stock warrants were excluded from the calculation of dilutive earnings per share.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

'

Stock Based Compensation

The Company accounts for all stock-based payments and awards under the fair value based method. Stock-based payments to non-employees are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The fair value of stock-based payments to non-employees is periodically re-measured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award and in the same manner as if the Company had paid cash instead of paying with or using equity based instruments on an accelerated basis. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable as at the grant date is measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term.

The Company accounts for the granting of share purchase options to employees using the fair value method whereby all awards to employees are recorded at fair value on the date of the grant. Share based awards granted to employees with a performance condition are measured based on the probable outcome of that performance condition during the requisite service period. Such an award with a performance condition is accrued if it is probable that a performance condition will be achieved. Compensation costs for stock-based payments to employees that do not include performance conditions are recognized on a straight-line basis. The fair value of all share purchase options is expensed over their vesting period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital

Stock-based compensation expense recognized for the years ended June 30, 2013 and 2012 was $187,210 and $103,668, respectively. No share purchase options were granted during such years. All previously granted options had been exercisable at the date of grant. The Company’s employee option plan was discontinued on June 6, 2012; all outstanding options had expired.

3_SUMMARY_OF_SIGNIFICANT_ACCOU1

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Jun. 30, 2013
Accounting Policies [Abstract]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	'The derivative liability at June 30, 2013 was valued using the Black Scholes Merton valuation model with the following estimates used significant inputs:
	Exercise Price			0.01			–		0.5
	Term			0.07			–	3.25 years
	Volatility			70.65	%		–		299.63	%
	Risk Free Rate of Return			0.02	%		–		0.66	%
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'Summary of Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis
							Fair Value Measurement Using
	30-Jun-13		Carrying Value				Level 1				Level 2			Level 3			Total
	Derivative conversion feature liability		$	-			$	-			$	-		$	-		$	-
	Derivative warrant liability			5,999,435											5,999,435			5,999,435
						Fair Value Measurement Using
	30-Jun-12	Carrying Value				Level 1				Level 2			Level 3			Total
	Derivative conversion feature liability		$	920,427			$				$			$	920,427		$	920,427
	Derivative warrant liability			7,947				-				-			7,947			7,947

4_COMMON_STOCK_AND_PREFERRED_S1

4. COMMON STOCK AND PREFERRED STOCK (Tables)	12 Months Ended
	Jun. 30, 2013
Stockholders' Equity Note [Abstract]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'Summary of the warrants is as follows:
		30-Jun-13						30-Jun-12
					Weighted						Weighted
					Average						Average
		Warrants			Exercise Price			Warrants			Exercise Price
	Outstanding at beginning of the period		97,616,000		$	0.237			98,307,667		$	0.237
	Issued		216,375,000			0.01			1,766,667			0.04
	Exercised		-						-
	Forfeited		-						-
	Expired		(6,063,333	)		(0.06	)		(2,458,334	)		(0.37	)
	Outstanding at end of period		307,927,667			0.18			97,616,000			0.24
	Exercisable at end of period		307,927,667		$	0.184			97,616,000			0.237

5_PROPERTY_EQUIPMENT_AND_PURCH1

5. PROPERTY, EQUIPMENT AND PURCHASED SOFTWARE (Tables)	12 Months Ended
	Jun. 30, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'Property, equipment and purchased software are stated at cost and consist of the following:
		June 30,
		2013			2012
	Furniture and fixtures	$	2,600	$	2,600
	Software		72,430		72,430
	Equipment		252,883		252,883
			327,913		327,913
	Less Accumulated Depreciation & Amortization		327,913		327,913
		$	-0-	$	0-

9_NOTES_PAYABLE_IN_DEFAULT_Tab

9. NOTES PAYABLE IN DEFAULT (Tables)	12 Months Ended
	Jun. 30, 2013
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'Notes payable and accrued interest at June 30, 2013 and 2012 consisted of the following:
		June 30,		June 30,
		2013		2012
	(1) Convertible note bearing interest at 17.98% per annum, as amended due on June 30, 2008, in default, convertible at $1.00 per share or 150,000 common shares at June 30, 2013.	$	150,000	$	150,000
	(2) Convertible note bearing interest at 8% per annum, increased to 22% when defaulted. (See below for variable terms of conversion). These notes were originally $180,000 borrowed and were past due, originally due on varying dates ranging from December 29, 2010 through March 8, 2011.  They have been completely converted to equity as of September 2012.		-		62,450
	(3) Convertible notes bearing interest at 20% per annum with a conversion price of $0.05 per share at June 30, 2013 - past due, originally due on December 30, 2009		306,858		268,066
	(4) Convertible note bearing interest at 10% per annum with a conversion price of $0.05 per share – 1,327,680 shares at June 30, 2013  - past due, originally due on July 26, 2010		66,384		61,342
	(5) Secured convertible note bearing interest at 18%-24% per annum with a conversion into Preferred B series shares at a  price of $125,000 per share, amended on July 1, 2012 and now due on June 30, 2013		1,513,964		1,220,395
	(6) Secured convertible note bearing interest at 8%-18% per annum with a conversion into Preferred B series shares at a price of $125,000 per share. amended on July 1, 2012 and now due on June 30, 2013		1,836,473		1,695,914
	(7) Note executed in May 2002 bearing interest at 8% per annum, originally due in November 2008		370,200		329,086
	(8) Note executed in May 2002 bearing interest at 8% per annum, no maturity date		371,387		365,463
	(9) Three notes executed from September 22, 2009 through January 11, 2011		35,000		75,000
	(10) Note executed in July 2011 bearing interest at 18%, maturity extended to August 23, 2013		170,095		161,920
	Total notes payable, all deemed current, due to various defaults as discussed below	$	4,820,361	$	4,389,636
	(1) 17.98% - Hospice convertible debenture – Originally due on September 30, 2004.  The note has been revised to accrue interest of $50,000 through September 30, 2004, the original due date.  The effective interest rate is 17.98%.  The debenture was to begin to be paid in January 2007 over a period of 18 months at a monthly amount of $8,333. The bondholder had agreed to no additional interest beyond September 30, 2004.  The Company is in breach of this agreement as of January 2007 and thereafter as a result of not making payments and is in default. The Company has not received a response from the note holder regarding a settlement proposal.  This note is unsecured and continues in default.
	(2) Asher convertible notes payable, with interest at 8%, which increased to 22% upon default of payment, were converted to equity by September 6, 2012.  These notes, consisting of principal and accrued interest of $45,000 and $17,450, respectively, at June 30, 2012 were converted into 60,778,706 of common shares in September 2012.  The shares issued for the year ended June 30, 2012 for the conversions from debt to equity was 52,630,130.  The conversion price was variable and equal to 58% multiplied by the market price, representing a 42% discount).  The market price was defined as the average of the lowest three trading prices for the common stock during the 10 trading days prior to the conversion date. Interest expense was $20,549 in 2013 was and $8,843 in 2012.
	(3) Schneller convertible notes payable originated on December 23, 2008 with a loan of $100,000 with a maturity date of December 31, 2009. If the loan was not repaid by the designated date there was a loan redemption fee of $50,000.  The $100,000 bears interest at 20%. The accrued interest payable was $156,858 and $118,066 for June 30, 2013 and 2012, respectively.  Interest expense was $38,792 and $38,792 for the years ended June 30, 2013 and 2012.  The Company is in default on this note as of December 31, 2009 and thereafter.  This note is unsecured.  Mr. Schneller has been appointed to the Board of Directors post June 30, 2013 and the audit committee.  Since this note has been in default the Company has been accruing financing costs that reflect the value of common shares and warrants every 90 days that this note remains in default.  The note holder earns every 90 days of default 2,672,000 of common shares and 2,672,000 warrants that are being recorded based on the stock value.  As of June 30, 2013, there were 36,072,000 of common shares and 36,072,000 of warrants to purchase common stock (warrants have a 5 year term and a $.01 exercise price). The value of the accrued financing costs for the of 36,072,000 common shares and 36,072,000 warrants as of June 30, 2013 was $638,786.
	(4) Koeting convertible note payable, with interest at 10%, originated on March 26, 2010 with a loan to the Company of $50,000 payable on July 26, 2010. There was accrued interest payable at June 30, 2013 and 2012 of $16,383 and $11,342, respectively.  The Company is in default on this note as of July 26, 2010 and thereafter.  The Company has sought an extension and has not received a response. This note is unsecured.  Interest expense for the years ended June 30, 2013 and 2012 was $5,041 and $5,041, respectively.
	(5) The note amount of $1,074,450 was lent by Sonoran Pacific Resources (a related party to a shareholder who has significant ownership in the Company and an interest in this entity) over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $439,514 at June 30, 2013 for a total note balance at such date of $1,513,964.  There was accrued interest payable of $286,196 at June 30, 2012 for a total note balance at such date of $1,220,395. As of July 1, 2012, an amended and restated loan agreement was signed which stated that the note was deemed not in default.  Interest rates have been 18% from September 15, 2010 to May 31, 2011, 20% from June 1, 2011 to June 30, 2011 and 24% from July 1, 2011 to June 30, 2012.  The interest rate from July 1, 2012 to June 30, 2013 will be at 10% and will increase to 12% if the note is extended, at the Company’s option, beyond June 30, 2013.  If the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. As part of the amended loan agreement the note was extended to June 30, 2014 Also, the Company issued 50 million common shares as part of a prior commitment dated June 2, 2011and agreed to issue an additional 50,000,000 shares relating to the July 1, amended and restated loan agreement.  In addition, the agreement includes an issue of 100,000,000 warrants at an exercise price of $.01, expiring in four years.  This note and the one described below in (6) are convertible into Preferred B stock at $125,000 per share based on the total outstanding note balances at the dates of conversion.  This note is secured by all assets of the Company.
	(6) The note amount of $1,190,457 was also lent by Sonoran Pacific Resources over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $646,016 at June 30, 2013 for a total note balance at such date of $1,836,473.  There was accrued interest payable of $505,457 at June 30, 2012 for a total note balance at such date of $1,695,914. There was a Replacement Secured Convertible Promissory Note in the original amount of $1,395,452 having an original date of April 17, 2010 and a Replacement Date of January 1, 2011.  As of July 1, 2012, an amended loan agreement was signed that the note was deemed not in default. Interest rates were 8% from 1/1/11 to 9/30/11 and 18% from October 1, 2011 to June 30, 2012.  The interest rate from July 1, 2012 to June 30, 2013is10% and will increase to 12% if the note is extended as set forth for the note detailed above.   Similarly, if the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. The interest expense was $140,559 and $306,426 for the years ended June 30, 2013 and 2012, respectively.  This note is secured by all assets of the Company.
	The above convertible notes are convertible into an aggregate of 23.33 shares of Series “B” preferred stock. (See Note 4).
	(7) On October 20, 2005, the Company agreed to repurchase shares of several shareholders referred to as the Wellbrock Group; the shares were exchanged for a $300,000 three-year note to be amortized over ten years at 8%.  The shares of stock are held in escrow until the notes are completely paid.  If there are any late payments per the payment schedule, the shares are to be released from escrow and to revert back to the original shareholders.  As of September 30, 2007 and June 30, 2007 the amounts owed were $293,199 and $298,188, respectively. The first ten monthly payments of principal and interest were to be in installments of $1,000 and the remaining 26 payments were to be in installments of $3,640.  The balloon payment of $272,076 was due on November 1, 2008.  The balloon balance was subsequently paid down to $263,492, but no further payments were made. The Company continues to be in default on this note.  The Company has sought an extension/modification and has not received a response.  The Company continues to accrue interest at 8%.  The accrued interest payable was $106,708 and $65,595 at June 30, 2013 and 2012, respectively.  The total note balances at such dates were $370,200 and $329,086, respectively. Interest expense for the years then ended was $41,114 in 2013 and $21,254 in 2012.
	(8) One of the Company’s former directors has lent funds in varying amounts beginning November 5, 2010.  Outstanding principal totals were $271,693 and $344,576 at June 30, 2013 and 2012, respectively. Interest payable accrued at 8% totaled of $299,694 and $20,887 at such dates for total balances outstanding of $371,387 and $365,463, respectively. There is no maturity. Interest expense was $78,807 and $34,994, respectively for the years ending June 30, 2013 and 2012.
	(9) There were three and four notes payable totaling $35,000 and $75,000 and were unsecured as of June 30, 2013 and 2012, respectively. In November 2012, $40,000 of debt plus accrued interest of $31,250 was converted into 4 million shares of common stock. The amounts were lent on various dates and are all non-interest bearing. The Company is in default on these notes and has sought an extension, but has not received a response these lenders.
	(10) Genesis Finance Corporation loaned the Company $155,000 during fiscal 2012. The note accrues interest at 18%.  The note was being paid in installments of $2,325 on the 25th of each month.  On August 26, 2012 an amended promissory note extended the maturity date to February 27, 2013. On January 30, 2013 there was an additional extension of six months to August 23, 2013.  The Company agreed to pay a 2% extension fee in the amount of $3,100 upon signing and to deposit $6,975 to be used to make monthly payments for March, April and May 2013. In connection with the debt extensions, the Company agreed to issue an aggregate of 1,000,000 shares to Genesis, which shares were issued subsequently.  ).  This note is guaranteed by Sonoran Pacific Resources.  Accrued interest expense was $20,150 and $6,920 at June 30, 2013 and June 30, 2012, respectively.

10_DERIVATIVE_LIABILITIES_Tabl

10. DERIVATIVE LIABILITIES (Tables)	12 Months Ended
	Jun. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of Derivative Instruments [Table Text Block]	'The following tabular presentation reflects the components of derivative financial instruments on the Company’s balance sheet at June 30, 2013 and 2012 and provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended June 30, 2013:
		JUNE 30,
		2013			2012
	Tainted warrants and Preferred shares	$	-0-		$	755,085
	Warrants in excess of authorized shares		5,999,435			-0-
	Embedded conversion features – Asher Notes		-0-			173,289
	Total	$	5,999,435		$	928,374
	Reconciliation in Change of Level 3 Values
	Beginning Balance	$	928,374		$	980,568
	Gain/(loss) on change in value-Derivative Warrants		5,999,435			-0-
	Income (loss) recognized from debt redemption		(49,672	)		(42,180	)
	Change in Derivative Liability – Conversion		(878,702	)		(10,014	)
	Ending Balance	$	5,999,435		$	928,374

11_INCOME_TAXES_Tables

11. INCOME TAXES (Tables)	12 Months Ended
	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'Deferred tax assets comprise the following at June 30, 2013 and June 30, 2012, respectively.
		June 30,
		2013			2012
	Deferred Income Tax Assets	$	15,879,453		$	12,270,894
	Valuation Allowance		(15,879,453	)		(12,270,894	)
	Net Deferred Tax Asset	$	-0-		$	-0-
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	Reconciliation of the effective income tax rate to the federal statutory rate:
	Federal income tax rate		34	%		34	%
	Change in valuation allowance on net operating loss carry-forwards		(34.0	)		(34.0	)
	Effective income tax rate		0	%		0	%

12_CONCENTRATION_OF_CREDIT_RIS1

12. CONCENTRATION OF CREDIT RISK (Tables)	12 Months Ended
	Jun. 30, 2013
Risks and Uncertainties [Abstract]	'
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	'Revenue concentrations for the year ended June 30, 2013 and 2012 and the accounts receivables concentrations at June 30, 2013 and 2012 are as follows:
		Net Sales for the Year Ended						Accounts receivable At
		June 30,			June 30,			June 30,			June 30,
		2013			2012			2013			2012
	Customer A		52.5	%		43.3	%		0	%		0	%
	Customer B		18.1	%		20.1			0	%		0	%
													%
			70.6	%		63.4	%		0	%		0	%

2_GOING_CONCERN_Details

2. GOING CONCERN (Details) (USD $)	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
Going Concern [Abstract]	'	'	'
Retained Earnings (Accumulated Deficit)	($55,232,300)	($47,986,879)	'
Stockholders' Equity Attributable to Parent	-12,789,974	-7,920,373	-3,561,901
Working Capital (Deficit)	($12,789,974)	'	'

3_SUMMARY_OF_SIGNIFICANT_ACCOU2

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]	'	'
Cash, FDIC Insured Amount	$250,000	'
Cash, Uninsured Amount	125,457	'
Property, Plant and Equipment, Depreciation Methods	'straight-line method	'
Property, Plant and Equipment, Estimated Useful Lives	'five to seven years	'
Allowance for Doubtful Accounts Receivable, Current	0	47,000
Allowance for Doubtful Accounts Receivable, Noncurrent	0	558,000
Provision for Doubtful Accounts	94,832	477,000
Advertising Expense	12,737	12,145
Share-based Compensation	$187,210	$103,668
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	0	0
Series A Preferred Stock [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	35.75	28
Series B Preferred Stock [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	26.13	18.75
Preferred A and B Shares Potentially Convertible into Common Shares [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	961,611,570	'
Warrant [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	307,927,667	97,616,000
Convertible Debt Securities [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	374,512,266	'

3_SUMMARY_OF_SIGNIFICANT_ACCOU3

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value Measurements, Significant Inputs (USD $)	12 Months Ended
	Jun. 30, 2013
Minimum [Member]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'
Exercise Price (in Dollars per share)	$0.01
Term	'25 days
Volatility	70.65%
Risk Free Rate of Return	0.02%
Maximum [Member]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'
Exercise Price (in Dollars per share)	$0.50
Term	'3 years 3 months
Volatility	299.63%
Risk Free Rate of Return	0.66%

3_SUMMARY_OF_SIGNIFICANT_ACCOU4

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value of Financial Assets and Liabilities (USD $)	Jun. 30, 2013	Jun. 30, 2012
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value of Financial Assets and Liabilities [Line Items]	'	'
Derivative conversion feature liability	$0	$920,427
Derivative warrant liability	5,999,435	7,947
Fair Value, Inputs, Level 1 [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value of Financial Assets and Liabilities [Line Items]	'	'
Derivative conversion feature liability	0	0
Derivative warrant liability	0	0
Fair Value, Inputs, Level 2 [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value of Financial Assets and Liabilities [Line Items]	'	'
Derivative conversion feature liability	0	0
Derivative warrant liability	0	0
Fair Value, Inputs, Level 3 [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value of Financial Assets and Liabilities [Line Items]	'	'
Derivative conversion feature liability	0	920,427
Derivative warrant liability	5,999,435	7,947
Netting [Member]	'	'
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value of Financial Assets and Liabilities [Line Items]	'	'
Derivative conversion feature liability	0	920,427
Derivative warrant liability	$5,999,435	$7,947

4_COMMON_STOCK_AND_PREFERRED_S2

4. COMMON STOCK AND PREFERRED STOCK (Details) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Common Stock, Shares, Outstanding	997,299,586	415,462,433
Common Stock, Shares Authorized	2,000,000,000	600,000,000
Warrants, Fair Value (in Dollars)	'	$52,380
Stock Issued During Period, Value, Issued for Services (in Dollars)	6,583,435	103,668
Stock Issued During Period, Value, Acquisitions (in Dollars)	421,053	'
Debt Conversion, Original Debt, Amount (in Dollars)	154,214	126,896
Preferred Stock, Shares Authorized	100,000,000	'
Equity Issued for Cash [Member] | Series A Preferred Stock [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, New Issues	7.5	'
Equity Issued for Cash [Member] | Series B Preferred Stock [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, New Issues	7.375	'
Equity Issued for Cash [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, New Issues	153,750,000	'
Class of Warrant or Rights, Granted	71,500,000	'
Proceeds from Issuance or Sale of Equity (in Dollars)	2,034,375	'
Warrants, Fair Value (in Dollars)	2,209,593	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Share)	$0.01	'
Equity Issued for Cash [Member] | Minimum [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Warrants, Term of Warrants	'2 years	'
Equity Issued for Cash [Member] | Maximum [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Warrants, Term of Warrants	'5 years	'
HITS Consulting [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Issued for Services	6,000,000	'
Stock Issued During Period, Value, Issued for Services (in Dollars)	59,400	'
Stock issued for account payable [Member] | Common Stock [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Other	3,500,000	'
Stock Issued During Period, Value, Other (in Dollars)	3,500	'
Stock issued for account payable [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Other	3,500,000	'
Stock Issued During Period, Value, Other (in Dollars)	105,000	'
Conversion of Debt and Interest [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Class of Warrant or Rights, Granted	2,500,000	'
Warrants, Fair Value (in Dollars)	54,226	'
Stock Issued During Period, Shares, Conversion of Convertible Securities	64,778,710	'
Debt Conversion, Original Debt, Amount (in Dollars)	154,214	'
Stock issued for loan extension fee [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Class of Warrant or Rights, Granted	100,000,000	'
Warrants, Fair Value (in Dollars)	348,482	'
Stock Issued During Period, Shares, Other	100,000,000	'
Stock Issued During Period, Value, Other (in Dollars)	213,944	'
Stock issued as finder's fees [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Class of Warrant or Rights, Granted	42,375,000	'
Warrants, Fair Value (in Dollars)	1,161,572	'
Stock Issued During Period, Shares, Other	104,946,670	'
Stock Issued During Period, Value, Other (in Dollars)	3,058,739	'
Stock issued for services, acquisition fees, accrued expenses and consulting [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Other	83,100,057	'
Stock Issued During Period, Value, Other (in Dollars)	3,310,752	'
Stock issued for outstanding convertible debt [Member] | Series B Preferred Stock [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Conversion of Convertible Securities	23.33	'
Warrants issued with debt [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Class of Warrant or Rights, Granted	'	1,766,667
Common Stock [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, New Issues	153,750,000	'
Stock Issued During Period, Shares, Issued for Services	288,046,721	24,830,774
Stock Issued During Period, Value, Issued for Services (in Dollars)	288,047	24,830
Stock Issued During Period, Shares, Acquisitions	10,526,316	'
Stock Issued During Period, Value, Acquisitions (in Dollars)	10,526	'
Stock Issued During Period, Shares, Conversion of Convertible Securities	64,778,710	52,630,132
Chief Executive Officer [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Share-based Compensation, Gross	20,401,250	'
Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars)	187,210	'
Series A Preferred Stock [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Preferred Stock, Shares Authorized	37	37
Preferred Stock, Shares Issued	35.75	28
Preferred Stock, Shares Outstanding	35.75	28
Preferred Stock, Conversion Basis	'convertible into a 1% ownership interest in the Company's common stock on a non-dilutive basis, giving effect to the conversion of all outstanding preferred shares, convertible debt and the exercise of all outstanding common stock purchase warrants, on a post-converted basis	'
Series B Preferred Stock [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Preferred Stock, Shares Authorized	63	63
Preferred Stock, Shares Issued	26.13	18.75
Preferred Stock, Shares Outstanding	26.13	18.75
Preferred Stock, Conversion Basis	'represented a 1% ownership interest in the Company's common stock, on a non-dilutive basis, giving effect to the conversion of all outstanding preferred shares, convertible debt and the exercise of all outstanding common stock purchase warrants, on a post-converted basis	'
Preferred Stock, Dividend Payment Terms	'If declared, dividends were payable in shares of Common Stock on the holders total investment per share of Series B Preferred Stock at an annual variable rate, which decreased from an initial rate of 18% to 14% and then for calendar 2012 and thereafter to 10% on the last day of each March, June, September and December of each year until such time as the Series B Preferred Stock was either converted into shares of Common Stock as provided in the Series B designation or redeemed through the sale, acquisition or merger of the Company resulting from a change of ownership of the Company.	'
Technology Software from JTJ Capital [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Acquisitions	34,834,156	'
Stock Issued During Period, Value, Acquisitions (in Dollars)	1,060,016	'
ClariDIS Corporation [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Acquisitions	10,526,316	'
Stock Issued During Period, Value, Acquisitions (in Dollars)	$421,053	'
Minimum [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Share)	$0.01	$0.01
Warrants, Term of Warrants	'25 days	'25 days
Maximum [Member]	'	'
4. COMMON STOCK AND PREFERRED STOCK (Details) [Line Items]	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Share)	$0.40	$0.24
Warrants, Term of Warrants	'3 years 3 months	'3 years 3 months

4_COMMON_STOCK_AND_PREFERRED_S3

4. COMMON STOCK AND PREFERRED STOCK (Details) - Schedule of Warrants (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Number of Warrants [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Outstanding at beginning of the period	97,616,000	98,307,667
Issued	216,375,000	1,766,667
Exercised	0	0
Forfeited	0	0
Expired	-6,063,333	-2,458,334
Outstanding at end of period	307,927,667	97,616,000
Exercisable at end of period	307,927,667	97,616,000
Weighted Average Exercise Price [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Outstanding at beginning of the period (in Dollars per share)	0.237	0.237
Issued (in Dollars per share)	0.01	0.04
Exercised (in Dollars per share)	0	0
Forfeited (in Dollars per share)	0	0
Expired (in Dollars per share)	-0.06	-0.37
Outstanding at end of period (in Dollars per share)	0.18	0.237
Exercisable at end of period (in Dollars per share)	0.184	0.237

5_PROPERTY_EQUIPMENT_AND_PURCH2

5. PROPERTY, EQUIPMENT AND PURCHASED SOFTWARE (Details) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Property, Plant and Equipment [Abstract]	'	'
Depreciation	$0	$0

5_PROPERTY_EQUIPMENT_AND_PURCH3

5. PROPERTY, EQUIPMENT AND PURCHASED SOFTWARE (Details) - Schedule of Property, Plant and Equipment (USD $)	Jun. 30, 2013	Jun. 30, 2012
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	$327,913	$327,913
Less Accumulated Depreciation & Amortization	327,913	327,913
	0	0
Furniture and Fixtures [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	2,600	2,600
Computer Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	72,430	72,430
Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	$252,883	$252,883

6_TECHNOLOGY_AND_MEDICAL_SOFTW1

6. TECHNOLOGY AND MEDICAL SOFTWARE (Details) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
6. TECHNOLOGY AND MEDICAL SOFTWARE (Details) [Line Items]	'	'
Impairment of Intangible Assets (Excluding Goodwill)	$1,257,058	$854,579
Technology-Based Intangible Assets [Member]	'	'
6. TECHNOLOGY AND MEDICAL SOFTWARE (Details) [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'60 months	'
Amortization of Intangible Assets	14,179	1,168,034
Impairment of Intangible Assets, Finite-lived	'	854,579
Impairment of Intangible Assets (Excluding Goodwill)	$1,084,057	'

7_CONSULTING_AGREEMENT_Details

7. CONSULTING AGREEMENT (Details) (HITS Consulting [Member], USD $)	12 Months Ended
	Jun. 30, 2013
HITS Consulting [Member]	'
7. CONSULTING AGREEMENT (Details) [Line Items]	'
Goodwill, Impaired, Accumulated Impairment Loss (in Dollars)	$59,400
Stock Issued During Period, Shares, Issued for Services	6,000,000
Class of Warrant or Rights, Granted	6,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	$0.02
Warrants, Term of Warrants	'3 years
Consulting Agreement Description	'A 90 daycontract was signed after which both parties could re-engage to negotiate, in good faith, an extension with terms to be determined by and agreed upon by both parties. The Company agreed to pay $10,000 in monthly salary for Henry Denis

8_ACQUISITIONS_Details

8. ACQUISITIONS (Details) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
8. ACQUISITIONS (Details) [Line Items]	'	'
Business Combination, Acquisition Related Costs	$400,016	$0
Stock Issued During Period, Value, Acquisitions	421,053	'
Revenues	105,692	595,506
Operating Expenses	9,115,401	4,695,395
Technology Software from JTJ Capital [Member]	'	'
8. ACQUISITIONS (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Acquisitions (in Shares)	34,834,156	'
Finite-lived Intangible Assets Acquired	660,000	'
Business Combination, Acquisition Related Costs	400,016	'
Stock Issued During Period, Value, Acquisitions	1,060,016	'
ClariDIS Corporation [Member]	'	'
8. ACQUISITIONS (Details) [Line Items]	'	'
Stock Issued During Period, Shares, Acquisitions (in Shares)	10,526,316	'
Business Combination Number of Shares Acquired (in Shares)	275,000	'
Stock Issued During Period, Value, Acquisitions	421,053	'
Shares Issued, Price Per Share (in Dollars per share)	$0.04	'
Revenues	0	'
Operating Expenses	$960	'

9_NOTES_PAYABLE_IN_DEFAULT_Det

9. NOTES PAYABLE IN DEFAULT (Details) (USD $)

12 Months Ended

8 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Jun. 30, 2013

Jun. 30, 2012

Feb. 18, 2014

Feb. 18, 2014

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2005

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2009

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2010

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2006

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2012

Subsequent Event [Member]

Subsequent Event [Member]

Principal [Member]

Interest [Member]

Series B Preferred Stock [Member]

Interest Rate from September 15, 2010 to May 31, 2011 [Member]

Hospice Convertible Debenture [Member]

Hospice Convertible Debenture [Member]

Hospice Convertible Debenture [Member]

Asher Convertible Notes [Member]

Asher Convertible Notes [Member]

Schneller Convertible Notes [Member]

Schneller Convertible Notes [Member]

Schneller Convertible Notes [Member]

Koeting Convertible Notes [Member]

Koeting Convertible Notes [Member]

Koeting Convertible Notes [Member]

Sonoran Pacific Resources Note 1 [Member]

Sonoran Pacific Resources Note 1 [Member]

Sonoran Pacific Resources Notes [Member]

Sonoran Pacific Resources Note 2 [Member]

Sonoran Pacific Resources Note 2 [Member]

Wellbrock Group Note [Member]

Wellbrock Group Note [Member]

Wellbrock Group Note [Member]

Former Director Note [Member]

Former Director Note [Member]

Three Notes Payable [Member]

Genesis Finance Corporation Note [Member]

Genesis Finance Corporation Note [Member]

Genesis Finance Corporation Note [Member]

Three Notes Payable [Member]

Three Notes Payable [Member]

Sonoran Pacific Resources Notes [Member]

Sonoran Pacific Resources Note 1 [Member]

9. NOTES PAYABLE IN DEFAULT (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Payable, Current

'

'

'

'

'

'

'

'

'

'

$50,000

'

$17,450

$156,858

$118,066

'

$16,383

$11,342

'

$439,514

$286,196

'

$646,016

$505,457

$106,708

$65,595

'

$299,694

$20,887

'

$20,150

$6,920

Debt Instrument, Payment Terms

'

'

'

'

'

'

'

'

'

'

'The debenture was to begin to be paid in January 2007 over a period of 18 months

'

'

'

'

'If the loan was not repaid by the designated date there was a loan redemption fee of $50,000

'

'

'

'

'

'

'

'

'

'

'The first ten monthly payments of principal and interest were to be in installments of $1,000 and the remaining 26 payments were to be in installments of $3,640.The balloon payment of $272,076 was due on November 1, 2008.The balloon balance was subsequently paid down to $263,492, but no further payments were made.

'

'

'

'The Company agreed to pay a 2% extension fee in the amount of $3,100 upon signing and to deposit $6,975 to be used to make monthly payments for March, April and May 2013.

'

Debt Instrument, Frequency of Periodic Payment

'

'

'

'

'

'

'

'

'

'

'monthly

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'each month

Debt Instrument, Periodic Payment

'

'

'

'

'

'

'

'

'

'

8,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,325

Debt Instrument, Interest Rate Terms

'

'

'

'

'

'

'

'

'

'

'The bondholder had agreed to no additional interest beyond September 30, 2004.

'

'

'

'

'

'

'

'

'Interest rates have been 18% from September 15, 2010 to May 31, 2011, 20% from June 1, 2011 to June 30, 2011 and 24% from July 1, 2011 to June 30, 2012.The interest rate from July 1, 2012 to June 30, 2013 will be at 10% and will increase to 12% if the note is extended, at the Company's option, beyond June 30, 2013.If the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured.

'

'

'Interest rates were 8% from 1/1/11 to 9/30/11 and 18% from October 1, 2011 to June 30, 2012.The interest rate from July 1, 2012 to June 30, 2013is10% and will increase to 12% if the note is extended as set forth for the note detailed above.Similarly, if the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured.

'

'

'

'

'

'

'non-interest bearing

'

'

Convertible Notes Payable, Current

'

'

'

'

'

'

'

'

'

'

'

'

45,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

'

'

'

'

'

'

'

'

150,000

150,000

'

60,778,706

52,630,130

'

'

'

1,327,680

'

'

'

'

'

'

'

'

'

'

'

'

4,000,000

'

'

Debt Instrument, Convertible, Terms of Conversion Feature

'

'

'

'

'

'

'convertible into an aggregate of 23.33 shares of Series "B" preferred stock

'

'

'

'

'

'The conversion price was variable and equal to 58% multiplied by the market price, representing a 42% discount).The market price was defined as the average of the lowest three trading prices for the common stock during the 10 trading days prior to the conversion date.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Expense

477,349

640,445

'

'

'

'

'

'

'

'

'

20,549

8,843

38,792

38,792

'

5,041

5,041

'

'

'

'

140,559

306,426

41,114

21,254

'

78,807

34,994

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

180,000

180,000

'

'

100,000

'

'

50,000

1,074,450

'

'

1,190,457

'

'

'

300,000

'

'

35,000

'

155,000

Debt Instrument, Default, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'The note holder earns every 90 days of default 2,672,000 of common shares and 2,672,000 warrants that are being recorded based on the stock value.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants, Term of Warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'4 years

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

$0.01

'

'

'

'

'

'

'

'

'

$0.01

'

'

'

'

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

Accrued Financing Costs, Warrants Issued (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

36,072,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accrued Financing Costs, Shares Issued (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

36,072,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accrued FInancing Cost, Value

'

'

'

'

'

'

'

'

'

'

'

'

'

638,786

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes Payable and Interest, Current

4,820,361

4,389,636

'

'

'

'

'

'

150,000

[1]

150,000

[1]

'

0

[2]

62,450

[2]

306,858

[3]

268,066

[3]

'

66,384

[4]

61,342

[4]

'

1,513,964

[5]

1,220,395

[5]

'

1,836,473

[6]

1,695,914

[6]

370,200

[7]

329,086

[7]

'

371,387

[8]

365,463

[8]

'

170,095

[9]

161,920

[9]

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

24.00%

17.98%

17.98%

'

8.00%

8.00%

20.00%

20.00%

'

10.00%

10.00%

'

10.00%

'

'

'

'

8.00%

8.00%

'

8.00%

8.00%

'

18.00%

18.00%

Debt Instrument, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'As part of the amended loan agreement the note was extended to June 30, 2014 Also, the Company issued 50 million common shares as part of a prior commitment dated June 2, 2011and agreed to issue an additional 50,000,000 shares relating to the July 1, amended and restated loan agreement.

'

'

'There was a Replacement Secured Convertible Promissory Note in the original amount of $1,395,452 having an original date of April 17, 2010 and a Replacement Date of January 1, 2011.

'

'

'

'three-year note to be amortized over ten years

'

'

'

'

'

Class of Warrant or Rights, Granted (in Shares)

'

'

'

12,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

'

'

'

$125,000

'

$1

$1

'

'

'

$0.05

$0.05

'

$0.05

$0.05

'

$125,000

$125,000

'

$125,000

$125,000

'

'

'

'

'

'

'

'

Debt Instrument, Collateral

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'This note is secured by all assets of the Company.

'

'

'

'

'

'

'

'

'This note is guaranteed by Sonoran Pacific Resources

'

Notes Payable, Current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

293,199

298,188

'

271,693

344,576

'

'

'

Debt Conversion, Original Debt, Amount

$154,214

$126,896

'

'

$40,000

$31,250

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Debt Default, Description of Notice of Default

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The Company is in default on these notes and has sought an extension, but has not received a response these lenders.

'

'

Stock Issued During Period, Shares, Extension of Debt (in Shares)

'

'

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

17.98% - Hospice convertible debenture - Originally due on September 30, 2004. The note has been revised to accrue interest of $50,000 through September 30, 2004, the original due date. The effective interest rate is 17.98%. The debenture was to begin to be paid in January 2007 over a period of 18 months at a monthly amount of $8,333. The bondholder had agreed to no additional interest beyond September 30, 2004. The Company is in breach of this agreement as of January 2007 and thereafter as a result of not making payments and is in default. The Company has not received a response from the note holder regarding a settlement proposal. This note is unsecured and continues in default.

[2]

Asher convertible notes payable, with interest at 8%, which increased to 22% upon default of payment, were converted to equity by September 6, 2012. These notes, consisting of principal and accrued interest of $45,000 and $17,450, respectively, at June 30, 2012 were converted into 60,778,706 of common shares in September 2012. The shares issued for the year ended June 30, 2012 for the conversions from debt to equity was 52,630,130. The conversion price was variable and equal to 58% multiplied by the market price, representing a 42% discount). The market price was defined as the average of the lowest three trading prices for the common stock during the 10 trading days prior to the conversion date. Interest expense was $20,549 in 2013 was and $8,843 in 2012.

[3]

Schneller convertible notes payable originated on December 23, 2008 with a loan of $100,000 with a maturity date of December 31, 2009. If the loan was not repaid by the designated date there was a loan redemption fee of $50,000. The $100,000 bears interest at 20%. The accrued interest payable was $156,858 and $118,066 for June 30, 2013 and 2012, respectively. Interest expense was $38,792 and $38,792 for the years ended June 30, 2013 and 2012. The Company is in default on this note as of December 31, 2009 and thereafter. This note is unsecured. Mr. Schneller has been appointed to the Board of Directors post June 30, 2013 and the audit committee. Since this note has been in default the Company has been accruing financing costs that reflect the value of common shares and warrants every 90 days that this note remains in default. The note holder earns every 90 days of default 2,672,000 of common shares and 2,672,000 warrants that are being recorded based on the stock value. As of June 30, 2013, there were 36,072,000 of common shares and 36,072,000 of warrants to purchase common stock (warrants have a 5 year term and a $.01 exercise price). The value of the accrued financing costs for the of 36,072,000 common shares and 36,072,000 warrants as of June 30, 2013 was $638,786.

[4]

Koeting convertible note payable, with interest at 10%, originated on March 26, 2010 with a loan to the Company of $50,000 payable on July 26, 2010. There was accrued interest payable at June 30, 2013 and 2012 of $16,383 and $11,342, respectively. The Company is in default on this note as of July 26, 2010 and thereafter. The Company has sought an extension and has not received a response. This note is unsecured. Interest expense for the years ended June 30, 2013 and 2012 was $5,041 and $5,041, respectively.

[5]

The note amount of $1,074,450 was lent by Sonoran Pacific Resources (a related party to a shareholder who has significant ownership in the Company and an interest in this entity) over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $439,514 at June 30, 2013 for a total note balance at such date of $1,513,964. There was accrued interest payable of $286,196 at June 30, 2012 for a total note balance at such date of $1,220,395. As of July 1, 2012, an amended and restated loan agreement was signed which stated that the note was deemed not in default. Interest rates have been 18% from September 15, 2010 to May 31, 2011, 20% from June 1, 2011 to June 30, 2011 and 24% from July 1, 2011 to June 30, 2012. The interest rate from July 1, 2012 to June 30, 2013 will be at 10% and will increase to 12% if the note is extended, at the Company's option, beyond June 30, 2013. If the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. As part of the amended loan agreement the note was extended to June 30, 2014 Also, the Company issued 50 million common shares as part of a prior commitment dated June 2, 2011and agreed to issue an additional 50,000,000 shares relating to the July 1, amended and restated loan agreement. In addition, the agreement includes an issue of 100,000,000 warrants at an exercise price of $.01, expiring in four years. This note and the one described below in (6) are convertible into Preferred B stock at $125,000 per share based on the total outstanding note balances at the dates of conversion. This note is secured by all assets of the Company.

[6]

The note amount of $1,190,457 was also lent by Sonoran Pacific Resources over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $646,016 at June 30, 2013 for a total note balance at such date of $1,836,473. There was accrued interest payable of $505,457 at June 30, 2012 for a total note balance at such date of $1,695,914. There was a Replacement Secured Convertible Promissory Note in the original amount of $1,395,452 having an original date of April 17, 2010 and a Replacement Date of January 1, 2011. As of July 1, 2012, an amended loan agreement was signed that the note was deemed not in default. Interest rates were 8% from 1/1/11 to 9/30/11 and 18% from October 1, 2011 to June 30, 2012. The interest rate from July 1, 2012 to June 30, 2013is10% and will increase to 12% if the note is extended as set forth for the note detailed above. Similarly, if the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. The interest expense was $140,559 and $306,426 for the years ended June 30, 2013 and 2012, respectively. This note is secured by all assets of the Company. The above convertible notes are convertible into an aggregate of 23.33 shares of Series "B" preferred stock. (See Note 4).

[7]

On October 20, 2005, the Company agreed to repurchase shares of several shareholders referred to as the Wellbrock Group; the shares were exchanged for a $300,000 three-year note to be amortized over ten years at 8%. The shares of stock are held in escrow until the notes are completely paid. If there are any late payments per the payment schedule, the shares are to be released from escrow and to revert back to the original shareholders. As of September 30, 2007 and June 30, 2007 the amounts owed were $293,199 and $298,188, respectively. The first ten monthly payments of principal and interest were to be in installments of $1,000 and the remaining 26 payments were to be in installments of $3,640. The balloon payment of $272,076 was due on November 1, 2008. The balloon balance was subsequently paid down to $263,492, but no further payments were made. The Company continues to be in default on this note. The Company has sought an extension/modification and has not received a response. The Company continues to accrue interest at 8%. The accrued interest payable was $106,708 and $65,595 at June 30, 2013 and 2012, respectively. The total note balances at such dates were $370,200 and $329,086, respectively. Interest expense for the years then ended was $41,114 in 2013 and $21,254 in 2012.

[8]

One of the Company's former directors has lent funds in varying amounts beginning November 5, 2010. Outstanding principal totals were $271,693 and $344,576 at June 30, 2013 and 2012, respectively. Interest payable accrued at 8% totaled of $299,694 and $20,887 at such dates for total balances outstanding of $371,387 and $365,463, respectively. There is no maturity. Interest expense was $78,807 and $34,994, respectively for the years ending June 30, 2013 and 2012.

[9]

Genesis Finance Corporation loaned the Company $155,000 during fiscal 2012. The note accrues interest at 18%. The note was being paid in installments of $2,325 on the 25th of each month. On August 26, 2012 an amended promissory note extended the maturity date to February 27, 2013. On January 30, 2013 there was an additional extension of six months to August 23, 2013. The Company agreed to pay a 2% extension fee in the amount of $3,100 upon signing and to deposit $6,975 to be used to make monthly payments for March, April and May 2013. In connection with the debt extensions, the Company agreed to issue an aggregate of 1,000,000 shares to Genesis, which shares were issued subsequently. ). This note is guaranteed by Sonoran Pacific Resources. Accrued interest expense was $20,150 and $6,920 at June 30, 2013 and June 30, 2012, respectively.

9_NOTES_PAYABLE_IN_DEFAULT_Det1

9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt (USD $)	Jun. 30, 2013		Jun. 30, 2012
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	$4,820,361		$4,389,636
Hospice Convertible Debenture [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	150,000	[1]	150,000	[1]
Asher Convertible Notes [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	0	[2]	62,450	[2]
Schneller Convertible Notes [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	306,858	[3]	268,066	[3]
Koeting Convertible Notes [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	66,384	[4]	61,342	[4]
Sonoran Pacific Resources Note 1 [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	1,513,964	[5]	1,220,395	[5]
Sonoran Pacific Resources Note 2 [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	1,836,473	[6]	1,695,914	[6]
Wellbrock Group Note [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	370,200	[7]	329,086	[7]
Former Director Note [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	371,387	[8]	365,463	[8]
Unsecured Notes Payable [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	35,000	[9]	75,000	[9]
Genesis Finance Corporation Note [Member]	'		'
9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt [Line Items]	'		'
Note	$170,095	[10]	$161,920	[10]
[1]	17.98% - Hospice convertible debenture - Originally due on September 30, 2004. The note has been revised to accrue interest of $50,000 through September 30, 2004, the original due date. The effective interest rate is 17.98%. The debenture was to begin to be paid in January 2007 over a period of 18 months at a monthly amount of $8,333. The bondholder had agreed to no additional interest beyond September 30, 2004. The Company is in breach of this agreement as of January 2007 and thereafter as a result of not making payments and is in default. The Company has not received a response from the note holder regarding a settlement proposal. This note is unsecured and continues in default.
[2]	Asher convertible notes payable, with interest at 8%, which increased to 22% upon default of payment, were converted to equity by September 6, 2012. These notes, consisting of principal and accrued interest of $45,000 and $17,450, respectively, at June 30, 2012 were converted into 60,778,706 of common shares in September 2012. The shares issued for the year ended June 30, 2012 for the conversions from debt to equity was 52,630,130. The conversion price was variable and equal to 58% multiplied by the market price, representing a 42% discount). The market price was defined as the average of the lowest three trading prices for the common stock during the 10 trading days prior to the conversion date. Interest expense was $20,549 in 2013 was and $8,843 in 2012.
[3]	Schneller convertible notes payable originated on December 23, 2008 with a loan of $100,000 with a maturity date of December 31, 2009. If the loan was not repaid by the designated date there was a loan redemption fee of $50,000. The $100,000 bears interest at 20%. The accrued interest payable was $156,858 and $118,066 for June 30, 2013 and 2012, respectively. Interest expense was $38,792 and $38,792 for the years ended June 30, 2013 and 2012. The Company is in default on this note as of December 31, 2009 and thereafter. This note is unsecured. Mr. Schneller has been appointed to the Board of Directors post June 30, 2013 and the audit committee. Since this note has been in default the Company has been accruing financing costs that reflect the value of common shares and warrants every 90 days that this note remains in default. The note holder earns every 90 days of default 2,672,000 of common shares and 2,672,000 warrants that are being recorded based on the stock value. As of June 30, 2013, there were 36,072,000 of common shares and 36,072,000 of warrants to purchase common stock (warrants have a 5 year term and a $.01 exercise price). The value of the accrued financing costs for the of 36,072,000 common shares and 36,072,000 warrants as of June 30, 2013 was $638,786.
[4]	Koeting convertible note payable, with interest at 10%, originated on March 26, 2010 with a loan to the Company of $50,000 payable on July 26, 2010. There was accrued interest payable at June 30, 2013 and 2012 of $16,383 and $11,342, respectively. The Company is in default on this note as of July 26, 2010 and thereafter. The Company has sought an extension and has not received a response. This note is unsecured. Interest expense for the years ended June 30, 2013 and 2012 was $5,041 and $5,041, respectively.
[5]	The note amount of $1,074,450 was lent by Sonoran Pacific Resources (a related party to a shareholder who has significant ownership in the Company and an interest in this entity) over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $439,514 at June 30, 2013 for a total note balance at such date of $1,513,964. There was accrued interest payable of $286,196 at June 30, 2012 for a total note balance at such date of $1,220,395. As of July 1, 2012, an amended and restated loan agreement was signed which stated that the note was deemed not in default. Interest rates have been 18% from September 15, 2010 to May 31, 2011, 20% from June 1, 2011 to June 30, 2011 and 24% from July 1, 2011 to June 30, 2012. The interest rate from July 1, 2012 to June 30, 2013 will be at 10% and will increase to 12% if the note is extended, at the Company's option, beyond June 30, 2013. If the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. As part of the amended loan agreement the note was extended to June 30, 2014 Also, the Company issued 50 million common shares as part of a prior commitment dated June 2, 2011and agreed to issue an additional 50,000,000 shares relating to the July 1, amended and restated loan agreement. In addition, the agreement includes an issue of 100,000,000 warrants at an exercise price of $.01, expiring in four years. This note and the one described below in (6) are convertible into Preferred B stock at $125,000 per share based on the total outstanding note balances at the dates of conversion. This note is secured by all assets of the Company.
[6]	The note amount of $1,190,457 was also lent by Sonoran Pacific Resources over the past several years at varying amounts to assist the Company for cash flow purposes. There is accrued interest payable of $646,016 at June 30, 2013 for a total note balance at such date of $1,836,473. There was accrued interest payable of $505,457 at June 30, 2012 for a total note balance at such date of $1,695,914. There was a Replacement Secured Convertible Promissory Note in the original amount of $1,395,452 having an original date of April 17, 2010 and a Replacement Date of January 1, 2011. As of July 1, 2012, an amended loan agreement was signed that the note was deemed not in default. Interest rates were 8% from 1/1/11 to 9/30/11 and 18% from October 1, 2011 to June 30, 2012. The interest rate from July 1, 2012 to June 30, 2013is10% and will increase to 12% if the note is extended as set forth for the note detailed above. Similarly, if the note is not repaid by June 30, 2014, the interest will increase to 18% until such latter default is cured. The interest expense was $140,559 and $306,426 for the years ended June 30, 2013 and 2012, respectively. This note is secured by all assets of the Company. The above convertible notes are convertible into an aggregate of 23.33 shares of Series "B" preferred stock. (See Note 4).
[7]	On October 20, 2005, the Company agreed to repurchase shares of several shareholders referred to as the Wellbrock Group; the shares were exchanged for a $300,000 three-year note to be amortized over ten years at 8%. The shares of stock are held in escrow until the notes are completely paid. If there are any late payments per the payment schedule, the shares are to be released from escrow and to revert back to the original shareholders. As of September 30, 2007 and June 30, 2007 the amounts owed were $293,199 and $298,188, respectively. The first ten monthly payments of principal and interest were to be in installments of $1,000 and the remaining 26 payments were to be in installments of $3,640. The balloon payment of $272,076 was due on November 1, 2008. The balloon balance was subsequently paid down to $263,492, but no further payments were made. The Company continues to be in default on this note. The Company has sought an extension/modification and has not received a response. The Company continues to accrue interest at 8%. The accrued interest payable was $106,708 and $65,595 at June 30, 2013 and 2012, respectively. The total note balances at such dates were $370,200 and $329,086, respectively. Interest expense for the years then ended was $41,114 in 2013 and $21,254 in 2012.
[8]	One of the Company's former directors has lent funds in varying amounts beginning November 5, 2010. Outstanding principal totals were $271,693 and $344,576 at June 30, 2013 and 2012, respectively. Interest payable accrued at 8% totaled of $299,694 and $20,887 at such dates for total balances outstanding of $371,387 and $365,463, respectively. There is no maturity. Interest expense was $78,807 and $34,994, respectively for the years ending June 30, 2013 and 2012.
[9]	There were three and four notes payable totaling $35,000 and $75,000 and were unsecured as of June 30, 2013 and 2012, respectively. In November 2012, $40,000 of debt plus accrued interest of $31,250 was converted into 4 million shares of common stock. The amounts were lent on various dates and are all non-interest bearing. The Company is in default on these notes and has sought an extension, but has not received a response these lenders.
[10]	Genesis Finance Corporation loaned the Company $155,000 during fiscal 2012. The note accrues interest at 18%. The note was being paid in installments of $2,325 on the 25th of each month. On August 26, 2012 an amended promissory note extended the maturity date to February 27, 2013. On January 30, 2013 there was an additional extension of six months to August 23, 2013. The Company agreed to pay a 2% extension fee in the amount of $3,100 upon signing and to deposit $6,975 to be used to make monthly payments for March, April and May 2013. In connection with the debt extensions, the Company agreed to issue an aggregate of 1,000,000 shares to Genesis, which shares were issued subsequently. ). This note is guaranteed by Sonoran Pacific Resources. Accrued interest expense was $20,150 and $6,920 at June 30, 2013 and June 30, 2012, respectively.

9_NOTES_PAYABLE_IN_DEFAULT_Det2

9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt (Parentheticals) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2009

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2010

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2006

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Hospice Convertible Debenture [Member]

Hospice Convertible Debenture [Member]

Asher Convertible Notes [Member]

Asher Convertible Notes [Member]

Schneller Convertible Notes [Member]

Schneller Convertible Notes [Member]

Schneller Convertible Notes [Member]

Koeting Convertible Notes [Member]

Koeting Convertible Notes [Member]

Koeting Convertible Notes [Member]

Sonoran Pacific Resources Note 1 [Member]

Sonoran Pacific Resources Note 1 [Member]

Sonoran Pacific Resources Note 2 [Member]

Sonoran Pacific Resources Note 2 [Member]

Wellbrock Group Note [Member]

Wellbrock Group Note [Member]

Wellbrock Group Note [Member]

Former Director Note [Member]

Former Director Note [Member]

Unsecured Notes Payable [Member]

Unsecured Notes Payable [Member]

Genesis Finance Corporation Note [Member]

Genesis Finance Corporation Note [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Unsecured Notes Payable [Member]

Unsecured Notes Payable [Member]

Unsecured Notes Payable [Member]

Unsecured Notes Payable [Member]

9. NOTES PAYABLE IN DEFAULT (Details) - Schedule of Debt (Parentheticals) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest at

17.98%

17.98%

8.00%

8.00%

20.00%

20.00%

'

10.00%

10.00%

'

10.00%

'

'

'

8.00%

8.00%

'

8.00%

8.00%

'

'

18.00%

18.00%

'

'

'

'

Convertible at (in Dollars per share)

$1

$1

'

'

$0.05

$0.05

'

$0.05

$0.05

'

$125,000

$125,000

$125,000

$125,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible shares (in Shares)

150,000

150,000

60,778,706

52,630,130

'

'

'

1,327,680

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due

30-Jun-08

30-Jun-08

8-Mar-11

8-Mar-11

30-Dec-09

30-Dec-09

'

26-Jul-10

26-Jul-10

'

30-Jun-13

30-Jun-13

30-Jun-13

30-Jun-13

30-Nov-08

30-Nov-08

'

'

'

'

'

23-Aug-13

23-Aug-13

'

'

'

'

Defaulted interest

'

'

22.00%

22.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes originally borrowed (in Dollars)

'

'

$180,000

$180,000

'

'

$100,000

'

'

$50,000

$1,074,450

'

$1,190,457

'

'

'

$300,000

'

'

'

'

'

$155,000

'

'

'

'

Converted to equity

'

'

30-Sep-12

30-Sep-12

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion price (in Dollars per share)

$1

$1

'

'

$0.05

$0.05

'

$0.05

$0.05

'

$125,000

$125,000

$125,000

$125,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion shares (in Shares)

150,000

150,000

60,778,706

52,630,130

'

'

'

1,327,680

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note, interest at

'

'

'

'

'

'

'

'

'

'

18.00%

18.00%

8.00%

8.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Note, interest at

'

'

'

'

'

'

'

'

'

'

24.00%

24.00%

18.00%

18.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Amended

'

'

'

'

'

'

'

'

'

'

1-Jul-12

1-Jul-12

1-Jul-12

1-Jul-12

'

'

'

'

'

'

'

'

'

'

'

'

'

Executed

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31-May-02

31-May-02

'

31-May-02

31-May-02

'

'

31-Jul-11

31-Jul-11

22-Sep-09

22-Sep-09

11-Jan-11

11-Jan-11

Maturity date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'no maturity date

'no maturity date

'

'

'

'

'

'

'

'

Notes

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Three

'Three

'

'

'

'

'

'

Maturity

30-Jun-08

30-Jun-08

8-Mar-11

8-Mar-11

30-Dec-09

30-Dec-09

'

26-Jul-10

26-Jul-10

'

30-Jun-13

30-Jun-13

30-Jun-13

30-Jun-13

30-Nov-08

30-Nov-08

'

'

'

'

'

23-Aug-13

23-Aug-13

'

'

'

'

10_DERIVATIVE_LIABILITIES_Deta

10. DERIVATIVE LIABILITIES (Details) (USD $)	Mar. 31, 3013	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'	'	'
Derivative Liability	$8,228,882	$5,999,435	$928,374	$980,568

10_DERIVATIVE_LIABILITIES_Deta1

10. DERIVATIVE LIABILITIES (Details) - Schedule of Derivative Instruments (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Mar. 31, 3013
Derivative [Line Items]	'	'	'
Derivative Liabilities	$5,999,435	$928,374	$8,228,882
Beginning Balance	928,374	980,568	8,228,882
Gain/(loss) on change in value-Derivative Warrants	5,999,435	0	'
Income (loss) recognized from debt redemption	-49,672	-42,180	'
Change in Derivative Liability b Conversion	-878,702	-10,014	'
Ending Balance	5,999,435	928,374	8,228,882
Tainted Warrants and Preferred Shares [Member]	'	'	'
Derivative [Line Items]	'	'	'
Derivative Liabilities	0	755,085	'
Ending Balance	0	755,085	'
Warrants in Excess of Authorized Shares [Member]	'	'	'
Derivative [Line Items]	'	'	'
Derivative Liabilities	5,999,435	0	'
Ending Balance	5,999,435	0	'
Embedded Conversion Features [Member] | Asher Convertible Notes [Member]	'	'	'
Derivative [Line Items]	'	'	'
Derivative Liabilities	0	173,289	'
Ending Balance	$0	$173,289	'

11_INCOME_TAXES_Details

11. INCOME TAXES (Details) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Income Tax Disclosure [Abstract]	'	'
Taxable Income (Loss)	$10,600,000	$4,600,000
Operating Loss Carryforwards	$47,000,000	$36,100,000

11_INCOME_TAXES_Details_Schedu

11. INCOME TAXES (Details) - Schedule of Deferred Tax Assets and Liabilities (USD $)	Jun. 30, 2013	Jun. 30, 2012
Schedule of Deferred Tax Assets and Liabilities [Abstract]	'	'
Deferred Income Tax Assets	$15,879,453	$12,270,894
Valuation Allowance	-15,879,453	-12,270,894
Net Deferred Tax Asset	$0	$0

11_INCOME_TAXES_Details_Schedu1

11. INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Schedule of Effective Income Tax Rate Reconciliation [Abstract]	'	'
Federal income tax rate	34.00%	34.00%
Change in valuation allowance on net operating loss carry-forwards	-34.00%	-34.00%
Effective income tax rate	0.00%	0.00%

12_CONCENTRATION_OF_CREDIT_RIS2

12. CONCENTRATION OF CREDIT RISK (Details) - Schedules of Concentration of Risk, by Risk Factor	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Customer A [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'
Concentration Risk [Line Items]	'	'
Customer	52.50%	43.30%
Customer A [Member] | Credit Concentration Risk [Member] | Accounts Receivable [Member]	'	'
Concentration Risk [Line Items]	'	'
Customer	0.00%	0.00%
Customer B [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'
Concentration Risk [Line Items]	'	'
Customer	18.10%	20.10%
Customer B [Member] | Credit Concentration Risk [Member] | Accounts Receivable [Member]	'	'
Concentration Risk [Line Items]	'	'
Customer	0.00%	0.00%
Customer A and B [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'
Concentration Risk [Line Items]	'	'
Customer	70.60%	63.40%
Customer A and B [Member] | Credit Concentration Risk [Member] | Accounts Receivable [Member]	'	'
Concentration Risk [Line Items]	'	'
Customer	0.00%	0.00%

13_INCOME_AND_BAD_DEBTS_Detail

13. INCOME AND BAD DEBTS (Details) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
13. INCOME AND BAD DEBTS (Details) [Line Items]	'	'
Revenues	$105,692	$595,506
Provision for Doubtful Accounts	94,832	477,000
Mass Mutual Insurance [Member]	'	'
13. INCOME AND BAD DEBTS (Details) [Line Items]	'	'
Revenues	'	260,000
Provision for Doubtful Accounts	62,000	'
Access Health [Member]	'	'
13. INCOME AND BAD DEBTS (Details) [Line Items]	'	'
Revenues	'	26,280
Provision for Doubtful Accounts	$26,280	'

14_COMMITMENTS_AND_CONTINGENCI1

14. COMMITMENTS AND CONTINGENCIES (Details) (USD $)	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2012	Jun. 30, 2008	Dec. 31, 2007	Dec. 31, 2006	Dec. 31, 2005	Jun. 30, 2005
			Chief Executive Officer [Member]	Chief Executive Officer [Member]	Chief Executive Officer [Member]	Chief Executive Officer [Member]	Chief Executive Officer [Member]	Chief Executive Officer [Member]
14. COMMITMENTS AND CONTINGENCIES (Details) [Line Items]	'	'	'	'	'	'	'	'
Employee-related Liabilities, Current	$703,531	$934,277	$157,210	'	'	'	'	'
Employment agreement, term	'	'	'	'2 years	'	'	'	'3 years
Salaries, Wages and Officers' Compensation	'	'	$144,000	'	$168,000	$130,000	$70,000	'
Other Commitments, Description	'	'	'	'	'The Agreement provided for 18 months of severance in the event of termination without cause.	'	'	'

15_SUBSEQUENT_EVENTS_Details

15. SUBSEQUENT EVENTS (Details) (USD $)	12 Months Ended		8 Months Ended					12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Feb. 18, 2014	Feb. 18, 2014	Feb. 18, 2014	Feb. 18, 2014	Feb. 18, 2014	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
			Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Minimum [Member]	Minimum [Member]	Maximum [Member]	Maximum [Member]
			Common Stock [Member]	Series B Preferred Stock [Member]		Minimum [Member]	Maximum [Member]
15. SUBSEQUENT EVENTS (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Proceeds from Issuance or Sale of Equity (in Dollars)	'	'	$656,250	'	'	'	'	'	'	'	'
Stock Issued During Period, Shares, New Issues	'	'	'	4.75	36,000,000	'	'	'	'	'	'
Class of Warrant or Rights, Granted	'	'	'	'	12,500,000	'	'	'	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	'	'	'	'	$0.01	'	'	$0.01	$0.01	$0.40	$0.24
Warrants, Term of Warrants	'	'	'	'	'	'18 months	'24 months	'25 days	'25 days	'3 years 3 months	'3 years 3 months
Stock Issued During Period, Shares, Issued for Services	'	'	'	'	19,312,500	'	'	'	'	'	'
Stock Issued During Period, Value, Issued for Services (in Dollars)	$6,583,435	$103,668	'	'	$634,250	'	'	'	'	'	'